<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">77073</article-id><article-id pub-id-type="doi">10.7554/eLife.77073</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>The structure-selective endonucleases GEN1 and MUS81 mediate complementary functions in safeguarding the genome of proliferating B lymphocytes</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Fernandez</surname><given-names>Keith Conrad</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3757-8271</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Feeney</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Smolkin</surname><given-names>Ryan M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Yen</surname><given-names>Wei-Feng</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Matthews</surname><given-names>Allysia J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Alread</surname><given-names>William</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Petrini</surname><given-names>John HJ</given-names></name><email>petrinij@mskcc.org</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Chaudhuri</surname><given-names>Jayanta</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3838-0075</contrib-id><email>chaudhuj@mskcc.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02yrq0923</institution-id><institution>Immunology Program, Memorial Sloan Kettering Cancer Center</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05bnh6r87</institution-id><institution>Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, Cornell University</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02yrq0923</institution-id><institution>Molecular Biology Program, Memorial Sloan-Kettering Cancer Center</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Gerstner Sloan Kettering Graduate School of Biomedical Sciences</institution><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05bnh6r87</institution-id><institution>Biochemistry, Cellular and Molecular Biology Allied Program, Weill Cornell Graduate School of Medical Sciences, Cornell University</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Heyer</surname><given-names>Wolf-Dietrich</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05rrcem69</institution-id><institution>University of California, Davis</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Tyler</surname><given-names>Jessica K</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02r109517</institution-id><institution>Weill Cornell Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>03</day><month>10</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e77073</elocation-id><history><date date-type="received" iso-8601-date="2022-01-14"><day>14</day><month>01</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-09-30"><day>30</day><month>09</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-02-10"><day>10</day><month>02</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.02.09.479711"/></event></pub-history><permissions><copyright-statement>© 2022, Fernandez, Feeney et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Fernandez, Feeney et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-77073-v5.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-77073-figures-v5.pdf"/><abstract><p>During the development of humoral immunity, activated B lymphocytes undergo vigorous proliferative, transcriptional, metabolic, and DNA remodeling activities; hence, their genomes are constantly exposed to an onslaught of genotoxic agents and processes. Branched DNA intermediates generated during replication and recombinational repair pose genomic threats if left unresolved, and so they must be eliminated by structure-selective endonucleases to preserve the integrity of these DNA transactions for the faithful duplication and propagation of genetic information. To investigate the role of two such enzymes, GEN1 and MUS81, in B cell biology, we established B-cell conditional knockout mouse models and found that deletion of GEN1 and MUS81 in early B-cell precursors abrogates the development and maturation of B-lineage cells while the loss of these enzymes in mature B cells inhibits the generation of robust germinal centers. Upon activation, these double-null mature B lymphocytes fail to proliferate and survive while exhibiting transcriptional signatures of p53 signaling, apoptosis, and type I interferon response. Metaphase spreads of these endonuclease-deficient cells show severe and diverse chromosomal abnormalities, including a preponderance of chromosome breaks, consistent with a defect in resolving recombination intermediates. These observations underscore the pivotal roles of GEN1 and MUS81 in safeguarding the genome to ensure the proper development and proliferation of B lymphocytes.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>B cell biology</kwd><kwd>DNA recombination</kwd><kwd>genome stability</kwd><kwd>holliday junction</kwd><kwd>structure-selective endonucleases</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01AI072194</award-id><principal-award-recipient><name><surname>Chaudhuri</surname><given-names>Jayanta</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01AI124186</award-id><principal-award-recipient><name><surname>Chaudhuri</surname><given-names>Jayanta</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R56AI072194</award-id><principal-award-recipient><name><surname>Chaudhuri</surname><given-names>Jayanta</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>U54CA137788</award-id><principal-award-recipient><name><surname>Chaudhuri</surname><given-names>Jayanta</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P30CA008748</award-id><principal-award-recipient><name><surname>Petrini</surname><given-names>John HJ</given-names></name><name><surname>Chaudhuri</surname><given-names>Jayanta</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01GM56888</award-id><principal-award-recipient><name><surname>Petrini</surname><given-names>John HJ</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R35GM136278</award-id><principal-award-recipient><name><surname>Petrini</surname><given-names>John HJ</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>U54OD020355</award-id><principal-award-recipient><name><surname>Petrini</surname><given-names>John HJ</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009859</institution-id><institution>Geoffrey Beene Cancer Research Center</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Chaudhuri</surname><given-names>Jayanta</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A novel conditional mouse model to interrogate the requirements of structure-selective endonucleases in the development, functionality, and genome stability of B lymphocytes.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>B lymphocytes comprise the humoral arm of the adaptive immune system. They undergo a well-orchestrated series of clonal expansion and differentiation programs in the bone marrow (BM) to become mature B cells that reside in secondary lymphoid organs such as the spleen and lymph nodes (<xref ref-type="bibr" rid="bib45">LeBien and Tedder, 2008</xref>; <xref ref-type="bibr" rid="bib71">Pieper et al., 2013</xref>). During an adaptive immune response, B cells are recruited into the germinal center (GC) where they adopt one of two cellular fates before exiting the GC: memory B cells that confer immunological memory and plasma cells that produce antibodies of high affinity and specificity (<xref ref-type="bibr" rid="bib58">Mesin et al., 2016</xref>; <xref ref-type="bibr" rid="bib88">Victora and Nussenzweig, 2022</xref>). B lymphocytes are unique among other immune cells in that they initiate programmed double-strand breaks (DSBs) both as developing precursors in the BM and as GC B cells in the secondary lymphoid organs (<xref ref-type="bibr" rid="bib2">Alt et al., 2013</xref>). V(D)J recombination generates a primary repertoire of B cell receptors that can be further diversified when GC B cells employ the DNA-modifying enzyme activation-induced cytidine deaminase (AID) to instigate the formation of DSBs in the immunoglobulin heavy loci (IgH) for class-switch recombination and to somatically hypermutate the variable regions of the immunoglobulin loci (<xref ref-type="bibr" rid="bib22">Feng et al., 2020</xref>; <xref ref-type="bibr" rid="bib79">Schatz and Swanson, 2011</xref>; <xref ref-type="bibr" rid="bib95">Xu et al., 2012</xref>). To outcompete other clonal cells and be selected for survival and differentiation, GC B cells not only are required to express the correct antigen-specific receptor of high affinity and specificity, but they must also satisfy the formidable replicative, transcriptional, and metabolic demands for clonal expansion (<xref ref-type="bibr" rid="bib97">Young and Brink, 2021</xref>). These cellular activities pose significant collateral genotoxic hazards to GC B cells; therefore, safeguarding the cells’ genomic integrity is paramount for accurate duplication and propagation of genetic information.</p><p>Impediments to the progression of the replication fork—termed replication stress—represent a significant endogenous source of DSBs in proliferating cells, producing up to 50 DSBs per cell cycle in a cell (<xref ref-type="bibr" rid="bib57">Mehta and Haber, 2014</xref>; <xref ref-type="bibr" rid="bib98">Zeman and Cimprich, 2014</xref>). Factors that impair the functionality of the replication machinery include repetitive sequences, secondary structures (such as R-loops and G-quadruplexes), transcription-replication conflicts, lesions such as thymidine dimers and single-stranded breaks, oxidative stress, and imbalance or depletion of the nucleotide pool (<xref ref-type="bibr" rid="bib98">Zeman and Cimprich, 2014</xref>). To ensure completion of DNA synthesis before mitosis commences, replication forks that have stalled or collapsed can be restarted via recombination-dependent or -independent pathways, the choice of which is contingent upon the nature of the replication barrier, the duration of stalling, the nature of the intermediates generated after fork stalling, and the type of processing these intermediates undergo (<xref ref-type="bibr" rid="bib5">Berti et al., 2020</xref>; <xref ref-type="bibr" rid="bib70">Petermann and Helleday, 2010</xref>; <xref ref-type="bibr" rid="bib98">Zeman and Cimprich, 2014</xref>). Though primarily studied in the context of DSB repair, proteins involved in homologous recombination (HR) including BRCA2 and RAD51 are also critical for the protection, remodeling, and recombination-dependent restart of replication forks, highlighting the necessity of HR in mitigating replication stress and assisting the timely completion of DNA synthesis (<xref ref-type="bibr" rid="bib1">Ait Saada et al., 2018</xref>; <xref ref-type="bibr" rid="bib8">Carr and Lambert, 2013</xref>; <xref ref-type="bibr" rid="bib81">Scully et al., 2021</xref>).</p><p>Recombination-dependent repair of DSBs and restart of replication forks entail strand invasion and homology search of an intact duplex DNA, generating a nascent joint intermediate termed the displacement loop (D-loop) that culminates in the formation of Holliday junctions (HJs) that physically link the two sister chromatids (<xref ref-type="bibr" rid="bib21">Falquet and Rass, 2019</xref>). Several mechanisms have evolved to process these intermediates, as failure to eliminate them prohibits chromosomal segregation during mitosis, interfering with the faithful transmission of genetic material to the daughter cells (<xref ref-type="bibr" rid="bib92">West and Chan, 2017</xref>). The BLM-TOP3A-RMI1-RMI2 (BTR) complex dissolves double HJs to generate non-crossover products while structure-selective endonucleases (SSEs) such as the SLX1-SLX4, MUS81-EME1, and XPF-ERCC1 (SMX) trinuclease complex and GEN1 resolve single and double HJs to generate both crossover and non-crossover products, depending on the position of the nicks introduced (<xref ref-type="bibr" rid="bib6">Blanco and Matos, 2015</xref>). Due to their in vitro 3′-flap endonuclease activity and the formation of 3′ flaps during synthesis-dependent strand annealing (SDSA), MUS81 complexes may also participate in the resolution of non-HJ-mediated recombination by cleaving such overhangs (<xref ref-type="bibr" rid="bib39">Hollingsworth and Brill, 2004</xref>). Moreover, <italic>mus81</italic> and <italic>yen1</italic> in <italic>Saccharomyces cerevisiae</italic> can process D-loops to influence the pathway choice and outcome of HR-mediated DSB repair as the absence of these enzymes promote break-induced replication (BIR) instead of SDSA (<xref ref-type="bibr" rid="bib36">Ho et al., 2010</xref>). Because these SSEs are active against a broad spectrum of branched DNA structures, they are subjected to multiple cell cycle-dependent regulatory mechanisms so that replication can proceed without interference and that toxic recombination outcomes due to uncontrolled cleavage are minimized (<xref ref-type="bibr" rid="bib94">Wild and Matos, 2016</xref>). Although the deletion of BLM itself causes embryonic lethality in mice, individual loss of GEN1 or MUS81 does not confer a strong DNA repair-deficient phenotype in unperturbed cells, implying some degree of functional overlap between the two proteins (<xref ref-type="bibr" rid="bib56">McDaniel et al., 2003</xref>; <xref ref-type="bibr" rid="bib77">Sarbajna et al., 2014</xref>). Only when GEN1 and MUS81 are both absent is the genomic integrity of the cells severely subverted, resulting in aberrant mitotic structures including bulky chromatin bridges and ultrafine anaphase bridges (UFBs) that lead to compromised viability, gross chromosomal mis-segregation and abnormalities, multinucleation, and heightened formation of micronuclei (<xref ref-type="bibr" rid="bib9">Chan et al., 2018</xref>; <xref ref-type="bibr" rid="bib10">Chan and West, 2018</xref>; <xref ref-type="bibr" rid="bib26">Garner et al., 2013</xref>; <xref ref-type="bibr" rid="bib77">Sarbajna et al., 2014</xref>; <xref ref-type="bibr" rid="bib78">Sarlós et al., 2017</xref>; <xref ref-type="bibr" rid="bib90">Wechsler et al., 2011</xref>; <xref ref-type="bibr" rid="bib91">West et al., 2015</xref>).</p><p>Besides removing HR intermediates arising from recombinational DNA transactions, both SSEs process persistent replication intermediates to promote the completion of genome replication and sister chromatid disentanglement (<xref ref-type="bibr" rid="bib21">Falquet and Rass, 2019</xref>). MUS81 complexes can cleave replication forks, structures resembling intact HJs such as four-way reversed forks, and D-loops to initiate and regulate BIR as a mechanism to repair dysfunctional forks (<xref ref-type="bibr" rid="bib30">Hanada et al., 2007</xref>; <xref ref-type="bibr" rid="bib40">Hua et al., 2022</xref>; <xref ref-type="bibr" rid="bib41">Kikuchi et al., 2013</xref>; <xref ref-type="bibr" rid="bib55">Mayle et al., 2015</xref>; <xref ref-type="bibr" rid="bib67">Pepe and West, 2014a</xref>; <xref ref-type="bibr" rid="bib68">Pepe and West, 2014b</xref>). MUS81 is also essential for the ‘expression’ of common fragile sites (CFSs)—sites that are prone to under-replication during stressed conditions—by cleaving stalled replication forks to enable POLD3-mediated mitotic DNA synthesis (MiDAS) (<xref ref-type="bibr" rid="bib14">Debatisse et al., 2012</xref>; <xref ref-type="bibr" rid="bib60">Minocherhomji et al., 2015</xref>; <xref ref-type="bibr" rid="bib63">Naim et al., 2013</xref>; <xref ref-type="bibr" rid="bib96">Ying et al., 2013</xref>). Generation of DSBs via MUS81-dependent cleavage of stalled replication forks, however, is not a prerequisite for HR-dependent replication restart as the uncoupling of the DNA strands at collapsed forks generates ssDNA that can invade and re-initiate DNA synthesis (<xref ref-type="bibr" rid="bib44">Lambert et al., 2010</xref>; <xref ref-type="bibr" rid="bib74">Rass, 2013</xref>). Though GEN1 has been implicated in maintaining replication fork progression alongside MUS81 and in eliminating persistent replication intermediates in Dna2 helicase-defective yeast cells to potentially facilitate MiDAS, its importance in rectifying replication stress and DNA under-replication in a genetically intact background remains to be determined (<xref ref-type="bibr" rid="bib65">Ölmezer et al., 2016</xref>; <xref ref-type="bibr" rid="bib77">Sarbajna et al., 2014</xref>).</p><p>The role of GEN1 and MUS81 in replication-challenged in vitro settings employing ionizing irradiation, DNA-damaging chemicals, and replication inhibitors is well established. Less is known, however, of these enzymes’ importance in an unperturbed in vivo context as the use of such genotoxic agents may not accurately reproduce the nature and composition of various DNA lesions generated during cellular proliferation. Because B cells face an elevated risk of cell death and oncogenic transformation due to the high level of replication stress and DSBs inflicted on their genome by AID-dependent and -independent activities (<xref ref-type="bibr" rid="bib2">Alt et al., 2013</xref>; <xref ref-type="bibr" rid="bib3">Barlow et al., 2013</xref>; <xref ref-type="bibr" rid="bib4">Basso and Dalla-Favera, 2015</xref>; <xref ref-type="bibr" rid="bib51">Macheret and Halazonetis, 2015</xref>), we asked whether B cells require GEN1 and MUS81 to develop, survive, and perform their immunological functions. By employing different stage-specific Cre strains and a global <italic>Gen1</italic>-knockout mouse carrying floxed <italic>Mus81</italic> alleles, we report that the loss of both <italic>Gen1</italic> and <italic>Mus81</italic> in early pro-B cells severely impaired B cell development whereas double-null mature B cells failed to form competent GCs at steady-state and after immunization. Ex vivo characterization of the endonuclease-knockout cells uncovered a proliferation block caused by G2/M arrest, potent activation of p53 and apoptotic pathways, induction of type I interferon (IFN) response, and widespread chromosomal aberrations. Our findings support the notion that the function of GEN1 and MUS81 in highly proliferative somatic cells such as B cells is in eliminating replication- and recombination-born junction and branched DNA molecules ranging from stalled and reversed replication forks to D-loops and dHJs to maintain replication and genomic fidelity, ensure proper chromosome segregation, and avert mitotic catastrophe.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>GEN1 and MUS81 are critical to normal B cell lymphopoiesis</title><p>We analyzed a publicly accessible RNA-seq data set (GSE72018) to ascertain the expression pattern of <italic>Gen1</italic> and <italic>Mus81</italic> in various developing and mature B cell subsets (<xref ref-type="bibr" rid="bib7">Brazão et al., 2016</xref>). Expression of <italic>Gen1</italic> is higher in the proliferating pro-B, pre-B, and GC B cells than in follicular B, marginal zone B, and peritoneal B1a cells (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Conversely, <italic>Mus81</italic> RNA expression is relatively similar across all B cell subsets examined except in peritoneal B1a cells (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). RT-qPCR analysis of primary splenic naïve B lymphocytes stimulated in culture with lipopolysaccharide (LPS) and interleukin-4 (IL-4) revealed a 10-fold increase in <italic>Gen1</italic> expression as early as 24-hr post-activation, while the expression of <italic>Mus81</italic> was not altered following activation (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). We surmise that <italic>Gen1</italic> expression is more closely associated with the activation and proliferation of B cells than is <italic>Mus81</italic> expression.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>B cell development in the bone marrow (BM) and spleen of <italic>Mb1</italic>-Cre <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> mice.</title><p>(<bold>A, B</bold>) mRNA expression of <italic>Gen1</italic> (<bold>A</bold>) and <italic>Mus81</italic> (<bold>B</bold>) in developing and mature B cell subsets in the BM, spleen, and peritoneal cavity. FO: follicular, MZ: marginal zone (GEO Accession: GSE72018). (<bold>C</bold>) Spleens harvested from 4-month-old mice of the indicated genotypes. (<bold>D, E</bold>) Gating strategy (<bold>D</bold>) and absolute quantification (<bold>E</bold>) of live splenocytes, splenic B220+CD43–B, and B220+CD43+B cells. (<bold>F</bold>) Gating strategy of total B (B220+TCRβ–), total T (B220–TCRβ+), mature recirculating, immature, pro-B (fractions B and C), early pre-B (fraction C′), and late pre-B cells (fraction D). (<bold>G–I</bold>) Absolute quantification of BM cellularity, total B, and total T cell populations (<bold>G</bold>), of mature recirculating and immature B cell populations (<bold>H</bold>), and of B cell populations belonging to fractions B to D (<bold>I</bold>). Data in (<bold>E</bold>) and (<bold>G–I</bold>) are from four independent experiments with 18–22 mice per genotype. Bars display the arithmetic mean and error bars represent the 95% confidence interval of the measured parameters. P values were enumerated using ordinary one-way ANOVA analysis with Dunnett’s multiple comparisons test without pairing wherein all means were compared to the <italic>Mb1</italic>-Cre <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> group. TPM, transcripts per million.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77073-fig1-v5.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Temporal expression of <italic>Gen1</italic> and <italic>Mus81</italic>, genetic structure of <italic>Gen1</italic><sup>−/−</sup> and <italic>Mus81</italic><sup>fl/fl</sup> alleles, Mendelian frequencies of <italic>Gen1</italic><sup>−/−</sup> and <italic>Mus81</italic><sup>−/−</sup> offsprings, and genotype validation of <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> and <italic>Mb1</italic>-Cre <italic>Gen1</italic><sup>+/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> pro-B cells.</title><p>(<bold>A</bold>) Relative quantification of <italic>Gen1</italic> and <italic>Mus81</italic> mRNA transcript levels by RT-qPCR in wild-type mouse B cells stimulated in lipopolysaccharide (LPS)+interleukin-4 (IL-4) culture from 24- to 96-hr post-stimulation. The expression level of the transcripts was normalized to the 0-hr time point. (<bold>B</bold>) Schematic of gene-targeting in generating the constitutive <italic>Gen1</italic><sup>−/−</sup> mouse model. The reading frame of exon 4 is disrupted with a floxed neomycin-resistance gene cassette that was subsequently excised upon Cre recombinase expression. (<bold>C</bold>) Tables depicting the observed and expected frequencies of the genotypes of pups generated from the indicated breeding schemes: G and M represent the wild-type alleles of <italic>Gen1</italic> and <italic>Mus81</italic>, respectively, whereas g and m represent the null alleles of <italic>Gen1</italic> and <italic>Mus81</italic>; d.f. denotes degree(s) of freedom. (<bold>D</bold>) Schematic of the <italic>Mus81</italic><sup>fl/fl</sup> allele in which exons 3–10 are flanked by loxP sites. When Cre recombinase is expressed under a tissue-specific promoter, exons 3 through 10 are excised, generating a null allele. The FRT site is a remnant of a pair that previously flanked a lacZ reporter-neomycin selection cassette. (<bold>E</bold>) Copy number quantification relative to control (<italic>Gen1</italic><sup>+/−</sup> <italic>Mus81</italic><sup>fl/fl</sup>) of unrecombined <italic>Mus81</italic><sup>fl/fl</sup> allele in fractions B+C cells isolated from the bone marrow of mice of the indicated genotypes. (<bold>F</bold>) Relative <italic>Gen1</italic> and <italic>Mus81</italic> mRNA expression in sorted fractions B+C cells. Data in (<bold>A</bold>) are from three independent experiments with seven mice per time point. Data in (<bold>E</bold>) and (<bold>F</bold>) are from two independent experiments with 4–6 mice per genotype.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77073-fig1-figsupp1-v5.tif"/></fig></fig-group><p>To interrogate the roles of GEN1 and MUS81 in B cell development and function, we generated <italic>Gen1</italic><sup>−/−</sup> mice by deleting the XPG nuclease domain encoded in exon 4 of <italic>Gen1</italic> and subsequently crossed them to <italic>Mus81</italic><sup>−/−</sup> mice (<xref ref-type="bibr" rid="bib16">Dendouga et al., 2005</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). Whereas <italic>Gen1</italic><sup>−/−</sup> and <italic>Mus81</italic><sup>−/−</sup> mice were born at the expected Mendelian frequencies, no live <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>−/−</sup> pups were produced, indicating that constitutive loss of both GEN1 and MUS81 leads to embryonic death (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). To circumvent this lethality, we generated floxed <italic>Mus81</italic> (<italic>Mus81</italic><sup>fl/fl</sup>) mice in which exons 3–10 encoding for the ERCC4 nuclease domain are flanked by loxP sites (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). We bred these mice to the <italic>Mb1</italic> (<italic>Cd79a</italic>)-Cre strain, wherein Cre recombinase expression is driven by the <italic>Cd79a</italic> promoter and the excision of the floxed allele is initiated at the pre-pro B cell stage (<xref ref-type="bibr" rid="bib20">Fahl et al., 2009</xref>; <xref ref-type="bibr" rid="bib37">Hobeika et al., 2006</xref>). The <italic>Mb1</italic>-Cre: <italic>Mus81</italic><sup>fl/fl</sup> mice were mated to <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> mice to produce the conditional knockout <italic>Mb1</italic>-Cre: <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup>, the single knockouts <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> and <italic>Mb1</italic>-Cre: <italic>Gen1</italic><sup>+/−</sup> <italic>Mus81</italic><sup>fl/fl</sup>, and the control <italic>Gen1</italic><sup>+/−</sup> <italic>Mus81</italic><sup>fl/fl</sup>.</p><p>We analyzed the spleen of the <italic>Mb1</italic>-Cre <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> mice and found that its cellularity was reduced by ninefold compared with that of control and single knockout mice (<xref ref-type="fig" rid="fig1">Figure 1C-E</xref>). The near complete ablation of mature B220+CD43+ and B220+CD43− cellular compartments indicated a significantly perturbed development or maintenance of peripheral B-lineage cells (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Examination of the BM revealed a 75% reduction in total cell number that was caused by the severe loss of the total B cell population; the T cell fraction remained unaltered (<xref ref-type="fig" rid="fig1">Figure 1F and G</xref>). Quantification of the B-lineage subpopulations showed that both immature and mature recirculating B cells were absent in the <italic>Mb1</italic>-Cre <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> BMs (<xref ref-type="fig" rid="fig1">Figure 1H</xref>), and that the endonuclease-deficient B cell progenitors produced few CD19<sup>+</sup> CD43<sup>+</sup> CD249<sup>–</sup> CD24<sup>var</sup> pro-B cells (<xref ref-type="fig" rid="fig1">Figure 1I</xref>). Quantitative genomic PCR of the unrecombined <italic>Mus81</italic><sup>fl/fl</sup> allele in <italic>Mb1</italic>-Cre: <italic>Gen1</italic><sup>+/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> pro-B (fractions B+C) cells confirmed efficient Cre-mediated deletion of the loxP-flanked exons (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). We further validated by RT-qPCR the absence of <italic>Gen1</italic> and <italic>Mus81</italic> mRNA expression in <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> and <italic>Mb1</italic>-Cre: <italic>Gen1</italic><sup>+/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> pro-B cells, respectively (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>). These findings indicate that <italic>Gen1</italic> and <italic>Mus81</italic> in early B-cell precursors are necessary for the differentiation, expansion, or maintenance of developing pro-B cells.</p></sec><sec id="s2-2"><title>GEN1 and MUS81 are required for robust GC responses</title><p>To circumvent the B cell developmental block in <italic>Mb1</italic>-Cre: <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> mice, we employed the <italic>Cd23</italic>-Cre deleter that expresses Cre specifically in naïve B cells under the control of a transgenic <italic>Cd23</italic> promoter (<xref ref-type="bibr" rid="bib43">Kwon et al., 2008</xref>). We crossed the <italic>Cd23</italic>-Cre strain to <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> mice, generating <italic>Cd23</italic>-Cre: <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> (designated henceforth as DKO), <italic>Cd23</italic>-Cre: <italic>Gen1</italic><sup>+/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> (<italic>Mus81</italic>-KO), <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> (<italic>Gen1</italic>-KO), <italic>Cd23</italic>-Cre: <italic>Gen1</italic><sup>+/−</sup> <italic>Mus81</italic><sup>fl/+</sup> (Cre control), and <italic>Gen1</italic><sup>+/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> (control) littermates. Though the B cell precursor subsets in the BM of the DKO mice did not exhibit any major alterations in their frequencies or absolute numbers (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A-D</xref>), the total BM cellularity was reduced by 30%, attributed to the 60% decrease in the number of the mature recirculating B cells (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). In the spleens of DKO mice, the frequencies and absolute numbers of the various B cell subsets were comparable to those of control and the <italic>Gen1</italic>-KO and <italic>Mus81</italic>-KO (collectively referred to as SKO) mice (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E-J</xref>). RT-qPCR analysis of splenic mature DKO B cells activated with LPS+IL-4 confirmed the ablation of <italic>Gen1</italic> and <italic>Mus81</italic> transcripts (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1K</xref>). These data show that the deletion of <italic>Gen1</italic> and <italic>Mus81</italic> in naïve, mature B cells does not markedly impact the development and maintenance of homeostatic B cell compartments; thus, the DKO mouse can serve as a genetic tool to investigate the requirement of <italic>Gen1</italic> and <italic>Mus81</italic> in activated, mature B cells.</p><p>We next characterized the impact of <italic>Gen1</italic> and <italic>Mus81</italic> deletion on the steady-state GC response in the mesenteric lymph nodes and Peyer’s patches—sites where B cells continuously encounter and are activated by microbial and food antigens (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). We found that the frequency and absolute number of GC B cells were decreased by 1.5- to 2-fold in DKO mice compared with control and SKO mice (<xref ref-type="fig" rid="fig2">Figure 2B and C</xref>). The presence of residual DKO GC B cells could be attributed to the selection of GC B cells that have escaped Cre-mediated deletion of the <italic>Mus81</italic><sup>fl/fl</sup> allele, as evidenced by the detection of unrecombined <italic>Mus81</italic><sup>fl/fl</sup> allelic copies and <italic>Mus81</italic> mRNA transcript within the DKO GC B cell population compared with the near-complete deletion of <italic>Mus81</italic><sup>fl/fl</sup> allele in the non-GC B cell counterpart (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A and B</xref>). <italic>Gen1</italic> mRNA expression, however, was absent in both DKO GC and non-GC B cells (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Homeostatic and induced GC responses in <italic>Cd23</italic>-Cre <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> mice.</title><p>(<bold>A–C</bold>) Homeostatic GC response in mesenteric lymph nodes and Peyer’s patches. (<bold>A</bold>) Flow cytometric plots depicting the GL7+Fas+GC B cells in the Peyer’s patches of mice for each indicated genotype. (<bold>B, C</bold>) Quantification of the frequencies and absolute numbers of the GL7+Fas+GC B cell population in the mesenteric lymph nodes (<bold>B</bold>) and Peyer’s patches (<bold>C</bold>). (<bold>D–F</bold>) Evaluation of GC response during SRBC challenge. (<bold>D</bold>) Representative plots of the GL7+Fas+GC B cell population isolated from the spleen of mice immunized with SRBC for each indicated genotype. (<bold>E, F</bold>) Quantification of the frequencies and absolute numbers of GC B cells (<bold>E</bold>) and of total B cells (<bold>F</bold>) in the spleen of SRBC-immunized mice. (<bold>G, H</bold>) Assessment of induced GC response upon NP-CGG challenge in the <italic>Cd23</italic>-Cre <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> mice at day 21 post-immunization. (<bold>G</bold>) Quantification of the percentage and absolute count of GL7+Fas+GC B cells in the spleen. (<bold>H</bold>) Frequencies and absolute numbers of live B220+ B cells in the spleen of PBS-treated and NP-CGG-immunized mice. Data in (<bold>B</bold>) and (<bold>C</bold>) are from four independent experiments with 11–21 mice per genotype. Data in (<bold>E</bold>) and (<bold>F</bold>) are from three independent experiments with 4–9 mice per genotype for the PBS group and 7–20 mice per genotype for the SRBC group. Data in (<bold>G</bold>) and (<bold>H</bold>) are from three independent experiments with 5–13 mice per genotype in the PBS group and 10–25 mice in the NP-CGG group. Bars represent the arithmetic mean and the error bars depict the 95% confidence interval of the measured parameters. For (<bold>B</bold>) and (<bold>C</bold>), p values were computed by ordinary one-way ANOVA analysis with Dunnett’s multiple comparisons test without pairing in which the means were compared to the <italic>Cd23</italic>-Cre <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> group. For (<bold>E–H</bold>), ordinary two-way ANOVA analysis with Dunnett’s multiple comparisons test without pairing was used to calculate the p values. All means were compared within each treatment group to the <italic>Cd23</italic>-Cre <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> cohort.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77073-fig2-v5.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Steady-state phenotyping and quantification of the splenic and bone marrow (BM) B cell populations in the <italic>Cd23</italic>-Cre <italic>Gen1</italic><sup>-/-</sup> <italic>Mus81</italic><sup>fl/fl</sup> mice.</title><p>(<bold>A</bold>) Quantification of BM cellularity and percentage of total B and T cell populations in the BMs of mice of the indicated genotypes. (<bold>B</bold>) Gating strategy of the B-cell populations in the BM: mature recirculating, immature, late-pre-B, and pro-B/early pre-B cells. (<bold>C</bold>) Quantification of the percentage among live B220+ B cells and absolute counts of mature recirculating and immature B cells. (<bold>D</bold>) Quantification of frequencies and absolute counts of late pre-B and pro-B/early pre-B cells among live B220+ B cells. (<bold>E</bold>) Representative flow cytometric plot depicting gating strategy of B220+CD43–B, B220+CD43+B, and non-B (B220–CD43+) cells in the spleen. (<bold>F, G</bold>) Quantification of the absolute number of live splenocytes (<bold>F</bold>), and of the percentage of splenic CD43–B, CD43+B, and non-B cells (<bold>G</bold>) in the mice of the indicated genotypes. (<bold>H</bold>) Gating strategy of the various splenic B cell subpopulations: marginal zone (MZ), follicular (FO), transitional-1 (T1), and transitional-2 (T2) B cells. (<bold>I</bold>) Frequencies of follicular and marginal zone B cells among total splenic B220+ cells. (<bold>J</bold>) Frequencies of T1 and T2 B cells among whole B220+B cells in the spleen. (<bold>K</bold>) Relative expression of <italic>Gen1</italic> and <italic>Mus81</italic> mRNA transcripts in LPS+IL-4-activated B cells of the indicated genotypes at 48 hr after stimulation. Data in (<bold>A–J</bold>) are from three independent experiments with 11–18 mice per genotype. Data in (<bold>K</bold>) are from three independent experiments with six mice per genotype. Bars depict the arithmetic mean and error bars represent the 95% confidence interval of the measured parameters. P values were calculated with ordinary one-way ANOVA analysis with Dunnett’s multiple comparisons test without pairing. All means were compared to the <italic>Cd23</italic>-Cre <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> group.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77073-fig2-figsupp1-v5.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Assessment of <italic>Mus81</italic> deletion efficiency in the germinal center by genomic qPCR and RT-qPCR analyses and examination of class switching in induced GCs in <italic>Cd23</italic>-Cre <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> mice.</title><p>(<bold>A</bold>) Quantification of the copy number relative to control (<italic>Gen1</italic><sup>+/−</sup> <italic>Mus81</italic><sup>fl/fl</sup>) of unrecombined <italic>Mus81</italic><sup>fl/fl</sup> allele in GC and non-GC B cells sorted from the Peyer’s patches. (<bold>B, C</bold>) Relative measurement of <italic>Mus81</italic> and <italic>Gen1</italic> mRNA transcript levels in GC and non-GC B cells purified from the Peyer’s patches. (<bold>D–G</bold>) Quantification of the frequency and absolute number of IgG1-switched GC B cells in the spleen of SRBC-immunized mice (<bold>D, E</bold>) and in the spleen of NP-CGG-challenged mice (<bold>F, G</bold>). Data in (<bold>A–C</bold>) are from two independent experiments with 6–7 mice per genotype. Data in (<bold>D</bold>) and (<bold>E</bold>) are from three independent experiments with 4–9 mice per genotype for the PBS group and 7–20 mice per genotype for the SRBC group. Data in (<bold>F</bold>) and (<bold>G</bold>) are from three independent experiment with 5–13 mice per genotype in the PBS group and 10–25 mice in the NP-CGG group. Bars display the arithmetic mean and the error bars depict the 95% confidence interval of the measured parameters. Ordinary two-way ANOVA analysis with Dunnett’s multiple comparisons test without pairing was used to calculate the p values. All means were compared within each treatment group to the <italic>Cd23</italic>-Cre <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> cohort.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77073-fig2-figsupp2-v5.tif"/></fig></fig-group><p>To assess the importance of GEN1 and MUS81 in supporting the formation and integrity of induced GCs, we immunized mice with sheep red blood cells (SRBCs) to elicit a T cell-dependent GC response. Mice were boosted 10 days after the primary dose and the GCs in the spleen were analyzed at day 14 (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Only in the DKO mice was GC formation abrogated: the frequency and absolute number of the GCs were 5% of that observed in control and SKO mice (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Within the sparse population of DKO GC B cells that we could reliably detect, the frequency of IgG1-switched cells was reduced by twofold compared to that in control and SKO GCs; more importantly, the absolute count of these switched DKO cells was almost negligible (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2D and E</xref>). Such disruption in GC formation and IgG1 class-switching was also observed when DKO mice were challenged with another T-cell-dependent antigen, NP-CGG (<xref ref-type="fig" rid="fig2">Figure 2G</xref> and <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2F and G</xref>). Despite the compromised GC response, the frequencies and absolute numbers of total B220+CD19+B cells in the immunized DKO mice were comparable to their SKO and control littermates (<xref ref-type="fig" rid="fig2">Figure 2F and H</xref>). These experiments indicate that although <italic>Gen1-Mus81</italic>-null naïve B cells can persist in the periphery, they are unable to mount a productive GC reaction upon antigenic exposure at the barrier sites and in secondary lymphoid organs.</p></sec><sec id="s2-3"><title>GEN1 and MUS81 are necessary for B cell proliferation and survival</title><p>To mechanistically investigate the causes underlying the abrogated GC response in the DKO mice, we leveraged a tractable ex vivo culture system wherein purified splenic naïve B cells are induced to proliferate upon stimulation with various cocktails of mitogens and cytokines. The expansion of splenic B cell cultures stimulated with LPS alone, LPS+IL-4 (LI), or LPS+TGF-β+anti-IgD dextran (LTD) was monitored by enumerating the live cells in culture using flow cytometry. Across all stimulation conditions, the DKO B cells were unable to expand—after 96 hr of culture, the number of live DKO cells was only 10% of that of control and SKO B cells (<xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). We then examined the proliferation dynamics of DKO B cells by labeling the cells with CellTrace Violet and tracking the dilution of the dye over time (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). We noted that at 72-hr post-stimulation, between 51% (LTD culture) and 68% (LPS culture) of the DKO cells had underwent at least three rounds of cell division, in contrast to between 72% (LTD culture) and 86% (LPS culture) of the corresponding control and SKO populations (<xref ref-type="fig" rid="fig3">Figure 3C</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). Although the DKO LI and LPS cultures contained a comparatively higher frequency of undivided (division zero) cells, the absolute numbers of division zero cells in both stimulations were similar across all genotypes, supporting the notion that the accumulation of division zero cells reflects a disproportionate representation of undivided DKO cells in the cultures caused by the progressive attrition of proliferating DKO cells, rather than by the specific inability of DKO cells to initiate cell division (<xref ref-type="fig" rid="fig3">Figure 3D</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). As cellular proliferation is intimately linked to class switching (<xref ref-type="bibr" rid="bib38">Hodgkin et al., 1996</xref>; <xref ref-type="bibr" rid="bib75">Rush et al., 2005</xref>), the lack of proliferative expansion of DKO B cells led to a minimal production of class-switched cells (<xref ref-type="fig" rid="fig3">Figure 3E</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Growth, proliferation, cell cycle, and cell death profiles of ex vivo-stimulated DKO B lymphocytes.</title><p>(<bold>A</bold>) Growth curve of LPS+IL-4 (LI)-activated B cell culture. (<bold>B</bold>) Representative CTV dilution profiles of ex vivo-activated B cells at 0- and 72-hr post-stimulation for all indicated genotypes and culture conditions. (<bold>C</bold>) Frequency of live B220+ cells in each division. (<bold>D</bold>) Absolute number of undivided (division zero) cells after 72 hr of LI culture. (<bold>E</bold>) Class switching of B lymphocytes to IgG1 at 72- and 96-hr post-activation quantified as absolute number of live IgG1-expressing B cells. (<bold>F</bold>) Representative flow cytometry plots delineating the cell cycle stages of the cultured B cells based on EdU positivity and nuclear DNA content as determined by the intensity of DAPI staining. (<bold>G</bold>) Frequency of live B cells in G0/G1, S, and G2/M phases after 48, 72, and 96 hours of activation. (<bold>H</bold>) Fraction of dead cells among B220+ singlets at 72 and 96 hr after LI activation. (<bold>I</bold>) Percentage of cleaved caspase-3+ cells among live cells at 48-, 72-, and 96-hr post-stimulation. (<bold>J</bold>) Frequency of cleaved caspase-3+ cells among live B220+ cells in G0/G1, S, and G2/M phases after 48, 72, and 96 hr of culture. Data in (<bold>A</bold>) are from four independent experiments with nine mice per genotype. Data in (<bold>C</bold>) and (<bold>D</bold>) are from four independent experiments with 7–9 mice per genotype. Data in (<bold>E</bold>) are from seven experiments with 17 mice per genotype. Data in (<bold>G</bold>) are from six independent experiments with 11–12 mice per genotype. Data in (<bold>H</bold>) are from seven experiments with 17 mice per genotype. Data in (<bold>I</bold>) are from five independent experiments with 9–10 mice per genotype. Data in (<bold>J</bold>) are from three independent experiments with six mice per genotype. Bars display the arithmetic mean and error bars represent the 95% confidence interval of the measured parameters. P values were determined using ordinary two-way ANOVA analysis with Dunnett’s multiple comparisons test without pairing wherein the mean of the <italic>Cd23</italic>-Cre <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> group was compared to the rest.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77073-fig3-v5.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Ex vivo characterization of DKO cells following LPS and LPS+TGF-β+anti-IgD-dextran (LTD) stimulations.</title><p>(<bold>A</bold>) Growth curve of LPS- and LTD-activated B cells. (<bold>B</bold>) Percentage of live B220+ cells in each division. (<bold>C</bold>) Absolute number of undivided (division zero) cells after 72 hr in LPS or LTD culture. (<bold>D</bold>) Class switching of B lymphocytes to IgG3 or IgA at 72- and 96-hr post-activation. Class-switched cells were quantified as absolute numbers of live IgG3- or IgA-expressing cells. (<bold>E, F</bold>) Cell cycle analysis of ex vivo-activated B cells. Frequency of cells among live B220+B cells in G0/G1, S, and G2/M phases at 48, 72, and 96 hr of LPS (<bold>E</bold>) or LTD (<bold>F</bold>) culture. Data in (<bold>A</bold>) are from four independent experiments with nine mice per genotype. Data in (<bold>B</bold>) and (<bold>C</bold>) are from three independent experiments with six mice per genotype. Data in (<bold>D</bold>) are from four independent experiments with nine mice per genotype. Data in (<bold>E</bold>) and (<bold>F</bold>) are from six independent experiments with 12 mice per genotype. Bars display the arithmetic mean and error bars represent the 95% confidence interval of the measured parameters. P values were determined using ordinary two-way ANOVA analysis with Dunnett’s multiple comparisons test without pairing wherein the mean of the <italic>Cd23</italic>-Cre <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> group was compared to the rest.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77073-fig3-figsupp1-v5.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Cell death profiles of DKO cells stimulated in LPS and LTD cultures.</title><p>(<bold>A</bold>) Frequency of dead cells quantified as percentage of B220+ singlets staining for the viability dye after 72 and 96 hr of culture in media with LPS or LPS+TGF-β+anti-IgD-dextran (LTD). (<bold>B</bold>) Apoptosis in ex vivo B cell cultures. Percentage of cleaved caspase-3+ cells within the live B cell population at 48-, 72-, and 96-hr post-stimulation. (<bold>C, D</bold>) Cell cycle-specific determination of apoptosis in ex vivo-activated B cells. Frequency of cleaved caspase-3+ cells among live B220+ cells in each phase at 48, 72, and 96 hr of LPS (<bold>C</bold>) or LTD (<bold>D</bold>) culture. Data in (<bold>A</bold>) are from four independent experiments with nine mice per genotype. Data in (<bold>B</bold>) are from five independent experiments with 8–10 mice per genotype. Data in (<bold>C</bold>) and (<bold>D</bold>) are from two (48 hr) or three (72- and 96-hr) independent experiments with 4–6 mice per genotype. Bars represent the arithmetic mean and the error bars depict the 95% confidence interval of the measured parameters. P values were calculated using ordinary two-way ANOVA analysis with Dunnett’s multiple comparisons test in which the means were compared to that of the <italic>Cd23</italic>-Cre <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> cohort.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77073-fig3-figsupp2-v5.tif"/></fig></fig-group><p>To gain additional insight into the proliferation defect sustained by the activated DKO cells, we analyzed the cell cycle profile of these cells. Cultured B cells were pulse labeled with the nucleoside analog EdU to mark cells in S phase and stained with FxCycle Violet (DAPI) to quantify DNA content; the proportion of cells in G0/G1, S, and G2/M phases was determined by flow cytometry (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). As early as 48-hr post-stimulation, the DKO cultures were enriched for cells in G2/M phase and depleted for cells in S phase (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). This skewed cell cycle distribution of the DKO cells persisted up till 96-hr post-activation and was observed in all culture conditions (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E and F</xref>). Additionally, in the LTD culture, the fraction of DKO cells in the G0/G1 stage was reduced across all the time points examined (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F</xref>). Altogether, these results suggest that the concomitant loss of GEN1 and MUS81 causes the cells to stall in G2/M, impeding the completion of the cell cycle.</p><p>Aside from the proliferation deficiency, we also observed a 2- to 3-fold higher proportion of dead cells in the DKO cultures relative to that in control and SKO cultures (<xref ref-type="fig" rid="fig3">Figure 3H</xref> and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>). To ascertain whether elevated apoptosis contributed to the perturbed expansion of DKO B cell cultures, we quantified by flow cytometry the frequency of cells that stained for anti-cleaved caspase-3 antibody. As early as 48-hr post-stimulation, the proportion of caspase-3+ cells was 2- to 5-fold higher in DKO cultures compared with control and SKO cultures. The size of the caspase-3+ population peaked at 72-hr post-stimulation before declining (LI and LTD cultures) or remaining unchanged (LPS culture) at 96-hr post-stimulation (<xref ref-type="fig" rid="fig3">Figure 3I</xref> and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B</xref>). When we quantified the fraction of caspase 3+ cells in the different cell cycle phases, we found that across all the time points and stimulation conditions examined, DKO cells in G2/M and G0/G1 phases experienced a 2- to 5-fold higher level of apoptosis than their control and SKO counterparts (<xref ref-type="fig" rid="fig3">Figure 3J</xref> and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2C and D</xref>). Taken together, these observations underscore an indispensable role for GEN1 and MUS81 in supporting the proliferative capacity and viability of activated B lymphocytes.</p></sec><sec id="s2-4"><title>Ablation of GEN1 and MUS81 induces p53 and type I interferon transcriptional programs</title><p>To assess the genome-wide transcriptional alterations underlying the proliferation and survival defects of ex vivo-activated DKO B cells, we conducted RNA-sequencing (RNA-seq) on activated B cells harvested at 48-hr post-stimulation, the time point at which the DKO cells were viable while displaying early signs of cell cycle perturbation and apoptosis. The RNA-seq analysis showed that the activated control and <italic>Gen1</italic>-KO B lymphocytes resembled each other transcriptomically, consistent with the lack of overt perturbations in <italic>Gen1</italic>-KO B cells (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Differential gene expression (DGE) analysis comparing <italic>Mus81</italic>-KO to control cells, however, identified 8 genes with a minimum of twofold upregulation in <italic>Mus81</italic>-KO cells (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). The induction of only a few genes in <italic>Mus81</italic>-KO cells could be explained by the mild proliferation and survival perturbations that we had observed in our in vivo and ex vivo experiments. Between <italic>Gen1</italic>-KO and <italic>Mus81</italic>-KO cells, the transcript level of only four genes, including <italic>Mus81,</italic> were differentially altered (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). These findings collectively illustrate that the deletion of either <italic>Gen1</italic> or <italic>Mus81</italic> alone does not substantially alter the transcriptional landscape of activated B lymphocytes.</p><p>DGE analysis of control versus DKO cells, on the contrary, revealed that 279 genes were upregulated by at least twofold (log<sub>2</sub> fold change≥1; FDR&lt;0.05) and 167 genes were downregulated by a minimum of log<sub>2</sub> fold change of –0.3 in the DKO B cells (corresponding to a ≥19% de-enrichment relative to control cells) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). To identify the functional modules to which the differentially expressed genes in the DKO cells belong, we performed gene set enrichment analysis (GSEA) with the Hallmark Gene Sets from the Molecular Signatures Database (MSigDB) (<xref ref-type="bibr" rid="bib49">Liberzon et al., 2015</xref>). We identified the p53 pathway (25/200 genes with log<sub>2</sub> fold change≥1; e.g., <italic>Ccng1, Zfp365, Plk2, Phlda3, Cdkn1a,</italic> and <italic>Zmat3</italic>) and apoptosis (15/161 genes with log<sub>2</sub> fold change≥0.5) signatures among the top five enriched gene sets whereas gene sets containing targets of the transcription factors MYC and E2F and genes involved in progression through the G2/M checkpoint were among the most de-enriched in the DKO cells (<xref ref-type="fig" rid="fig4">Figure 4B and C</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D-F</xref>), concurring with our findings that DKO cultures exhibit perturbed cell cycle progression, G2/M arrest, proliferation irregularities, and heightened apoptosis. We also noted that the ex vivo-activated DKO B cells displayed a robust type I IFN gene signature, as exemplified by the high enrichment score (NES=2.35; FDR=6.34×10<sup>–3</sup>) and the induction (log<sub>2</sub> fold change≥0.5) of 21/97 genes in the gene set (e.g., <italic>Ifit3, Ifit3b, Ifitm3, Mx1,</italic> and <italic>Rsad2</italic>) (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). We posit from this analysis that the deficiency of both GEN1 and MUS81 in cells activates p53-dependent pathways to arrest cell cycle for the repair of genomic insults sustained during cellular growth and proliferation, and to initiate apoptosis when such DNA lesions are beyond tolerance and repair.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>RNA-seq and gene set enrichment (GSEA) analyses of activated control and DKO B cells.</title><p>(<bold>A</bold>) Volcano plot depicting the differential gene expression between control and DKO cells. Labeled squares indicate the top 15 most significantly upregulated genes and the labeled triangles are the 10 most downregulated genes in DKO cells. Using the Hallmark Gene Sets as reference, genes labeled in blue are categorized as genes in the p53 pathway while those labeled in red are defined as interferon alpha (IFN-α) response genes. Purple symbols mark <italic>Gen1</italic> and <italic>Mus81</italic>. (<bold>B</bold>) Graph depicting the list of Hallmark Gene Sets that are differentially expressed between control and DKO cells (FDR&lt;0.05). Value in each bar denotes the FDR for that gene set. (<bold>C</bold>) Heatmaps displaying the relative expression of genes within the indicated Hallmark Gene Sets that meet the expression cutoff (log<sub>2</sub> fold change&gt;1 for p53 pathway; &gt;0.5 for apoptosis and interferon alpha response; &lt;–0.3 for G2/M checkpoint; with FDR&lt;0.05). Data are from six mice per genotype. The labels ‘1’ and ‘2’ represent male and female mice, respectively, and ‘A’ to ‘C’ indicate the three experimental ex vivo groups.</p><p><supplementary-material id="fig4scode1"><label>Figure 4—source code 1.</label><caption><title>R script to generate <xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="fig" rid="fig4">Figure 4</xref>, and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77073-fig4-code1-v5.zip"/></supplementary-material></p><p><supplementary-material id="fig4scode2"><label>Figure 4—source code 2.</label><caption><title>Bash script to clean and align FASTQ files.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77073-fig4-code2-v5.zip"/></supplementary-material></p><p><supplementary-material id="fig4scode3"><label>Figure 4—source code 3.</label><caption><title>Bash script to count gene alignments.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77073-fig4-code3-v5.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Differential expression between control and DKO B cells.</title></caption><media mimetype="application" mime-subtype="octet-stream" xlink:href="elife-77073-fig4-data1-v5.csv"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77073-fig4-v5.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Transcriptomics and gene set enrichment (GSEA) analyses of ex vivo-activated control, GKO, and MKO B cells.</title><p>(<bold>A</bold>) Table listing the first five genes and the corresponding log<sub>2</sub> fold change, p value, and FDR generated from the DESeq analysis comparing <italic>Gen1</italic><sup>+/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> (control) and <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> (GKO) B cells. (<bold>B</bold>) Volcano plot displaying the differential gene expression between control and <italic>Cd23</italic>-Cre <italic>Gen1</italic><sup>+/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> (MKO) cultures at 48-hr post-stimulation. Purple dots indicate the top 10 significantly upregulated genes, and the green dots indicate genes that are de-enriched. (<bold>C</bold>) Table listing the genes that are differentially expressed between GKO and MKO B cells. (<bold>D</bold>) GSEA plots of the Hallmark Gene Sets enriched in DKO cells. (<bold>E</bold>) GSEA plots of the Hallmark Gene Sets de-enriched in DKO cells. (<bold>F</bold>) Heatmap depicting the genes within the indicated Hallmark Gene Sets that had a log<sub>2</sub> fold change of ≤–0.3 and FDR of &lt;0.05 in DKO cells relative to control. Data are from six mice per genotype. The labels ‘1’ and ‘2’ represent male and female mice, respectively, and ‘A’ to ‘C’ denote the three experimental ex vivo groups.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Differential expression between control and GKO B cells.</title></caption><media mimetype="application" mime-subtype="octet-stream" xlink:href="elife-77073-fig4-figsupp1-data1-v5.csv"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata2"><label>Figure 4—figure supplement 1—source data 2.</label><caption><title>Differential expression between control and MKO B cells.</title></caption><media mimetype="application" mime-subtype="octet-stream" xlink:href="elife-77073-fig4-figsupp1-data2-v5.csv"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata3"><label>Figure 4—figure supplement 1—source data 3.</label><caption><title>Differential expression between GKO and MKO B cells.</title></caption><media mimetype="application" mime-subtype="octet-stream" xlink:href="elife-77073-fig4-figsupp1-data3-v5.csv"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77073-fig4-figsupp1-v5.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>In vivo and ex vivo phenotyping of DKO <italic>Trp53</italic>-WT, DKO <italic>Trp53</italic>-Het, and DKO <italic>Trp53</italic>-KO B cells.</title><p>(<bold>A, B</bold>) Absolute number of total B cells and frequency of GC B cells in the mesenteric lymph nodes (<bold>A</bold>) and Peyer’s patches (<bold>B</bold>) of mice for each indicated genotypes. (<bold>C</bold>) Growth curve of LPS+IL-4 (LI)-activated splenic B cell culture. (<bold>D</bold>) Representative CTV dilution plots of activated B cells at 72-hr post-stimulation. (<bold>E</bold>) Frequency of IgG1, IgG3, and IgA class-switched cells after 72 and 96 hr of stimulation in LI, LPS, and LTD cultures, respectively. (<bold>F</bold>) Cell cycle profile of LI-stimulated B cells after 48, 72, and 96 hr of culture represented by the frequency of live B cells in G0/G1, S, and G2/M phases. (<bold>G</bold>) Frequency of dead B cells at 48-, 72-, and 96-hr post LI-activation. (<bold>H</bold>) Fraction of live B cells undergoing apoptosis as defined by positive staining for anti-cleaved caspase-3 antibody after 48, 72, and 96 hr of LI culture. (<bold>I</bold>) Cell cycle phase-specific assessment of apoptosis. Frequency of cleaved caspase-3+ B cells in G0/G1, S, and G2/M phases at 48, 72, and 96 hr post-stimulation in LI culture. Data in (<bold>A–I</bold>) are from two independent experiments with 5–10 mice per genotype. Bars represent arithmetic mean and error bars denote 95% confidence intervals of the measured values. P values were computed using one-way ANOVA analysis (<bold>A, B</bold>) and two-way ANOVA analysis (<bold>E–I</bold>) with Dunnett’s multiple comparison test wherein the mean of the DKO <italic>Trp53</italic>-KO group was compared to the others.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77073-fig4-figsupp2-v5.tif"/></fig></fig-group></sec><sec id="s2-5"><title>p53 deficiency fails to ameliorate the proliferative and viability defects of GEN1-MUS81-double-null B cells</title><p>Since the DKO cells exhibit a strong p53 transcriptional signature that could drive their apoptosis and G2/M arrest, we wanted to determine whether the deletion of p53 would mitigate these detrimental events and restore the growth and functionality of DKO cells. To test this hypothesis, we bred <italic>Trp53</italic><sup>fl/fl</sup> mice to the DKO mouse to generate <italic>Cd23</italic>-Cre: <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> <italic>Trp53</italic><sup>fl/fl</sup> (DKO <italic>Trp53</italic>-KO) mice.</p><p>Examination of the GCs in the mLN and Peyer’s patches of DKO <italic>Trp53</italic>-KO mice and their p53-expressing littermates (DKO <italic>Trp53</italic>-WT and DKO <italic>Trp53</italic>-Het) revealed no difference in the absolute number of total B cells and in the frequency of GC B cells among these groups (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A and B</xref>). Likewise, growth curve and CellTrace Violet dilution analyses showed no alterations in the proliferative competence of DKO <italic>Trp53</italic>-KO B cells (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C and D</xref>). These cells, however, did exhibit small but incongruent differences in their class-switching capacities (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2E</xref>). Further, the cell cycle profile of the DKO <italic>Trp53</italic>-KO cells was not substantively different from that of the DKO <italic>Trp53</italic>-WT and DKO <italic>Trp53</italic>-Het cells (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2F</xref>).</p><p>Despite the comparable percentage of dead DKO cells independent of their p53 status (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2G</xref>), the DKO <italic>Trp53</italic>-KO B cells underwent reduced level of apoptosis at 48-hr post-stimulation compared with their p53-expressing counterparts (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2H</xref>). This decrease was not sustained at subsequent time points; instead, the fraction of apoptotic DKO <italic>Trp53</italic>-KO cells increased and became higher than that of p53-expressing DKO B cells (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2H</xref>). Assessment of apoptosis in the individual cell cycle phase showed that the temporal changes in the cell death of p53-null DKO cells occurred consistently in the G2/M phase (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2I</xref>). These data together show that the severe proliferative and survival deficiencies of DKO B cells cannot be overcome by the removal of p53.</p></sec><sec id="s2-6"><title>GEN1 and MUS81 maintain the genome stability of activated B lymphocytes</title><p>GEN1 and MUS81 resolve structural intermediates arising from replication and HR to prevent genome destabilization caused by the toxic accumulation of erroneously processed branched and joint DNA structures (<xref ref-type="bibr" rid="bib9">Chan et al., 2018</xref>; <xref ref-type="bibr" rid="bib77">Sarbajna et al., 2014</xref>). Reasoning that the genomic integrity of proliferating DKO B cells might similarly be compromised, we prepared metaphase spreads from ex vivo-stimulated B cells for evaluation of chromosomal integrity. DKO B cells displayed approximately six times as many abnormalities per metaphase as control and SKOs B cells (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>). Furthermore, whereas almost 95% of control and SKO metaphases had no more than two aberrations, 45% of DKO metaphases showed three or more chromosomal defects (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Chromosomal aberrations, including breaks, DNA fragments, fusions, and radials, were detected at an elevated rate in DKO B cells compared with control and SKOs cells (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Notably, 67% of the breaks observed were chromosome-type breaks that occur at the same position on both sister chromatids (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). To better understand the origins and nature of the chromosomal irregularities occurring in the activated DKO B cells, we performed telomere fluorescence in situ hybridization (Tel-FISH). In DKO cells, the breakage occurred proximal to the telomeres, resulting in paired DNA fragments containing telomeric DNA (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). Such symmetrical breakage has been proposed to arise from unresolved recombination intermediates (<xref ref-type="bibr" rid="bib26">Garner et al., 2013</xref>). Additionally, the Tel-FISH analysis revealed that the aberrations identified by Giemsa staining as acentric chromosomes in fact often involved two separate chromosomes, and thus likely represent a class of radials involving acrocentric short arms (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). These observations show that the absence of GEN1 and MUS81 engenders an assortment of chromosomal lesions in proliferating B cells.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Metaphase chromosomal analysis of activated DKO B cells.</title><p>(<bold>A</bold>) Representative image of a DKO metaphase spread with arrows indicating chromosomal breaks, fragments, and fusions in metaphases of activated DKO B cells. (<bold>B</bold>) Quantification of the average number of chromosomal aberrations across 45–50 metaphase spreads prepared from each B cell culture. (<bold>C</bold>) Percentage breakdown of metaphases exhibiting 0 to greater than 5 chromosomal aberrations. (<bold>D</bold>) Fraction of metaphases containing the indicated types of chromosomal abnormalities. Total percentage per genotype exceeds 100% as some metaphases exhibit more than one type of abnormality. (<bold>E</bold>) Proportion of chromatid and chromosome breaks among the 163 breaks observed in DKO metaphase spreads exhibiting at least one break. (<bold>F</bold>) Tel-FISH images of DKO metaphases highlighting the proximal location of the chromosomal damage to the telomeres. Note that the events labeled as dicentrics here and in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref> may include chromosomes with residual cohesins remaining at a repaired DSB and those with condensins that persist after loading onto the chromosomal arms during mitotic entry. Data in (<bold>B–E</bold>) are from three independent experiments with 5 mice (totaling between 215 and 235 metaphase spreads) per genotype. For (<bold>C</bold>), the percentages are the average of the data combined from all five mice. Bars display the arithmetic mean and error bars represent the 95% confidence interval of the measured parameters. P values were computed with ordinary one-way ANOVA analysis (<bold>B, D</bold>) and the Kruskal-Wallis test (<bold>C</bold>) with Dunnett’s multiple comparisons test without pairing. Means of all groups were compared to that of <italic>Cd23</italic>-Cre <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77073-fig5-v5.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Telomere FISH analysis of metaphase spreads prepared from ex vivo-activated DKO B cells.</title><p>Representative immunofluorescence images depicting in the context of stained telomeric DNA the various aberrations occurring in DKO B cells activated for 48 hr with LPS+IL-4.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77073-fig5-figsupp1-v5.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Proliferation dynamics, viability, and chromosomal analyses of DKO <italic>Aicda</italic>-Het and DKO <italic>Aicda</italic>-KO ex vivo cultures.</title><p>(<bold>A</bold>) Growth curves of activated DKO <italic>Aicda</italic>-Het and DKO <italic>Aicda</italic>-KO splenic B cells. (<bold>B, C</bold>) Proliferation dynamics of DKO <italic>Aicda</italic>-Het and DKO <italic>Aicda</italic>-KO B cells in ex vivo cultures. Representative CTV dilution plot at 72-hr post-stimulation (<bold>B</bold>) and percentage of cells in each cell division (<bold>C</bold>) quantified at 72 hr after activation with LPS+IL-4, LPS, and LTD. (<bold>D</bold>) Frequency of cleaved caspase-3+ cells among ex vivo-activated B cells at 48-, 72-, and 96-hr post-stimulation. (<bold>E</bold>) Quantification of the average number of chromosomal aberrations present across all metaphase spreads of B cells isolated from each mouse of the indicated genotypes and activated with LPS+IL-4 for 48 hr. Data in (<bold>A–C</bold>) are from five independent experiments with 14 mice per genotype. Data in (<bold>D</bold>) are from three independent experiments with 9–11 mice per genotype. Data in (<bold>E</bold>) are from three independent experiments with six mice for each indicated genotype. Between 298 and 300 metaphase spreads were examined for each genotype. Bars display the arithmetic mean and error bars represent the 95% confidence interval of the measured parameters. P values in (<bold>C</bold>) and (<bold>D</bold>) were calculated using mixed-effects two-way ANOVA analysis with Šidák multiple comparisons test. For (<bold>E</bold>), p values were enumerated using ordinary one-way ANOVA analysis with Dunnett’s multiple comparisons test without pairing.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77073-fig5-figsupp2-v5.tif"/></fig></fig-group><p>Because AID-instigated DSBs within and outside of the <italic>IgH</italic> loci constitute a source of DNA damage in B lymphocytes, we generated <italic>Cd23</italic>-Cre: <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> <italic>Aicda</italic><sup>−/−</sup> (DKO <italic>Aicda</italic>-KO) mice to ascertain whether ablation of AID can rescue the viability and proliferation defects of DKO B cells. Ex vivo culture studies showed that the deletion of AID did not restore the proliferative and survival capacities of DKO cells (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A-D</xref>). Additionally, the average number of chromosomal aberrations in the DKO <italic>Aicda</italic>-KO cells was similar to that of DKO <italic>Aicda</italic>-Het B cells (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2E</xref>). These findings illustrate that AID-driven DSBs contribute little to the severe proliferation and viability defects exhibited by <italic>Gen1-Mus81</italic>-null B lymphocytes and that the chromosomal aberrations occurring within the DKO B cells are likely caused by unrepaired replication-associated DNA damage.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>B cells encounter a diverse array of genotoxic stresses throughout their life cycle, of which DSBs—both spontaneously and deliberately generated—are considered among the most deleterious genomic lesions. HR constitutes one of the two major pathways cells utilize to repair DSBs. This mode of repair is largely restricted to late S and G2 phases as it requires the sister chromatid as a template to restore the fidelity of the damaged DNA strand (<xref ref-type="bibr" rid="bib35">Heyer, 2015</xref>). Recombinational repair of DSB lesions produces various joint and branched molecules that must be processed accurately and timely by SSEs to maintain the integrity of the genome (<xref ref-type="bibr" rid="bib6">Blanco and Matos, 2015</xref>; <xref ref-type="bibr" rid="bib15">Dehé and Gaillard, 2017</xref>). Due to their broad substrate specificity, SSEs are stringently regulated within a physiological environment via multiple mechanisms including binding with regulatory proteins and post-translational modifications that constrain their in vivo target recognition, thus endowing them with context-specific cellular functions (<xref ref-type="bibr" rid="bib94">Wild and Matos, 2016</xref>). To examine the genome-stabilizing role of GEN1 and MUS81 at various stages of B cell development, we established a <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> mouse model and utilized early and late B-cell-specific Cre drivers for the conditional deletion of MUS81. Inactivation of both enzymes in early B cell precursors abolished the production of mature B cells in the BM and periphery, whereas ablation in mature, naïve B cells impaired GC formation in response to antigenic stimulation. Ex vivo cellular and transcriptomics analyses revealed that these endonuclease-deficient B cells exhibited significant proliferation and viability perturbations underpinned by widespread chromosomal abnormalities and activation of cell cycle arrest and apoptosis in response to protracted p53 signaling elicited by extensive DNA damage.</p><p>The severe attrition of pro-B cells in the <italic>Mb1</italic>-Cre <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> mice could be caused by a developmental arrest during the transition from pre-pro B cell to pro-B cell stage, by proliferation and survival defects of the pro-B cells, or both. Pro-B cells, compared to the mitotically inactive pre-pro B cells, undergo IL-7R-dependent proliferative expansion prior to V(D)J recombination and so are more likely to suffer from intense replication stress that could necessitate commensurate effort of replication restart (<xref ref-type="bibr" rid="bib33">Hardy et al., 1991</xref>; <xref ref-type="bibr" rid="bib69">Peschon et al., 1994</xref>). As the SSE-knockout pro-B cells are unable to resolve both stalled replication forks and recombination-associated DNA structures formed during such restart activities, they would fail to thrive and proliferate further. Similarly, the lack of robust chronic and induced GC responses in the <italic>Cd23</italic>-Cre <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> mice can be ascribed to the inability of DKO cells to alleviate replication stress generated during sustained proliferation by eliminating replication-induced junction molecules, leading to G2/M stalling and abrogation of a complete cell division. High levels of concurrent DNA replication and transcriptional activities within the GC B cells could promote replication-transcription conflicts and R-loop formation that further exacerbate replication stress. We did not observe a time-dependent G2/M accumulation in the DKO culture, suggesting that the arrested DKO cells could not tolerate for long periods the high level of DNA damage incurred from multiple rounds of cell division and consequently undergo mitotic catastrophe, evidenced in the comparatively higher rate of apoptosis among cells in the G2/M phase. Resting mature DKO cells, however, persisted unscathed in the spleen, as exemplified by the normal frequencies and numbers of splenic B cell subpopulations in the <italic>Cd23</italic>-Cre <italic>Gen1</italic><sup>−/−</sup> <italic>Mus81</italic><sup>fl/fl</sup> mice. Splenic naïve B cells do not self-renew; instead, they are constantly replenished from immature precursors produced in the BM and maintained homeostatically by the survival signals BAFF and APRIL (<xref ref-type="bibr" rid="bib31">Hao and Rajewsky, 2001</xref>; <xref ref-type="bibr" rid="bib52">Mackay and Gommerman, 2015</xref>). Hence, resting mature B cells are spared from replication-derived genotoxicity, rendering GEN1 and MUS81 dispensable in these cells.</p><p>The inability of the BTR complex to compensate for the concomitant deficiencies of GEN1 and MUS81 and maintain the viability of proliferating DKO B cells suggests that DNA replication and recombination events generate persistent double HJs and multiple BTR-refractory HJ species such as single HJs and nicked HJs that must be resolved by these endonucleases to suppress genomic instability and catastrophic mitosis (<xref ref-type="bibr" rid="bib25">García-Luis and Machín, 2014</xref>). Nevertheless, the absence of these SSEs may also preclude the processing of aberrant replication intermediates that could deleteriously impact the genome duplication process and undermine the proliferative capacity of the cells. In particular, the MUS81-EME2 complex has been shown to mediate replication fork restart by endonucleolytic cleavage of stalled replication forks during S phase to protect genome integrity (<xref ref-type="bibr" rid="bib67">Pepe and West, 2014a</xref>). Although the in vivo relevance of GEN1 in processing such intermediates remains to be formally established, our genetic analysis and others suggest that when MUS81 is unavailable, GEN1 can potentially act on these substrates (or a processed form of them) that persist into mitosis upon nuclear breakdown to initiate HR-dependent fork restart (<xref ref-type="bibr" rid="bib25">García-Luis and Machín, 2014</xref>; <xref ref-type="bibr" rid="bib36">Ho et al., 2010</xref>; <xref ref-type="bibr" rid="bib77">Sarbajna et al., 2014</xref>). Deregulated mutagenic synthesis of the DNA strand during BIR can also contribute to the genomic instability of the DKO cells. Deficiency in these SSEs enables the uncleaved D-loop to undergo prolonged extension, promoting mutagenesis, template switching, and nonreciprocal loss of heterozygosity (<xref ref-type="bibr" rid="bib36">Ho et al., 2010</xref>; <xref ref-type="bibr" rid="bib55">Mayle et al., 2015</xref>). SSEs can presumably act on nascent D-loops to promote the less deleterious genetic outcome of half crossovers and on extended D-loops to restrict error-prone DNA synthesis (<xref ref-type="bibr" rid="bib55">Mayle et al., 2015</xref>; <xref ref-type="bibr" rid="bib80">Schwartz and Heyer, 2011</xref>). Alternatively, the inability to eliminate single HJ intermediates formed from the merger of an incoming replication fork with the extending D-loop may explain the genotoxicity of BIR in <italic>Gen1-Mus81</italic>-DKO cells (<xref ref-type="bibr" rid="bib55">Mayle et al., 2015</xref>). Although the disruption of the D-loop is central to the initiation of SDSA, no experimental evidence has emerged thus far to support such a role by MUS81, and we believe this to be highly unlikely due to its nicking mechanism. The MUS81 complexes, nonetheless, may be implicated in facilitating SDSA because of their 3′-flap cleavage activity (<xref ref-type="bibr" rid="bib39">Hollingsworth and Brill, 2004</xref>).</p><p>Our observation of extensive chromosomal aberrations in the endonuclease-null mouse B cells concur with that of <xref ref-type="bibr" rid="bib77">Sarbajna et al., 2014</xref> that employed siRNA depletion of <italic>Gen1</italic> and <italic>Mus81</italic> in cells treated with replication inhibitors. Recombination intermediates generated in S phase that fail to be resolved in the absence of GEN1 and MUS81 evade the checkpoint response and persist into mitosis, generating homologous recombination ultrafine bridges (HR-UFBs) (<xref ref-type="bibr" rid="bib9">Chan et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Mohebi et al., 2015</xref>; <xref ref-type="bibr" rid="bib86">Tiwari et al., 2018</xref>). Breakage of the HR-UFBs during cytokinesis engenders chromosomal breaks that activate the DNA damage checkpoint in the next cell cycle, triggering non-homologous end joining-mediated fusion of DNA ends that leads to widespread chromosomal rearrangements (<xref ref-type="bibr" rid="bib9">Chan et al., 2018</xref>). The preponderance of chromosome breaks that appear to occur at identical sites on sister chromatids suggest that the aberrations result from defective resolution of inter-chromatid recombination intermediates (<xref ref-type="bibr" rid="bib41">Kikuchi et al., 2013</xref>; <xref ref-type="bibr" rid="bib82">Shimizu et al., 2020</xref>; <xref ref-type="bibr" rid="bib90">Wechsler et al., 2011</xref>). This phenotype is distinct from that of irradiated HR-defective mutants in which chromatid breaks predominate (<xref ref-type="bibr" rid="bib24">Fujita et al., 2013</xref>; <xref ref-type="bibr" rid="bib82">Shimizu et al., 2020</xref>). Unresolved HJs have been implicated to impede DNA condensation in mitosis, manifesting as ‘pinches’ in the chromosome (<xref ref-type="bibr" rid="bib90">Wechsler et al., 2011</xref>); thus, a subset of the chromosome breaks observed in DKO cells may not be actual breaks but rather intact HJs. Although these chromosome-type breaks may also arise due to defective NHEJ, the established roles of GEN1 and MUS81 in HJ resolution render this explanation unlikely. We also cannot completely exclude the role of MUS81—and potentially GEN1—in cleaving stalled replication forks to initiate BIR and MiDAS at CFS and other under-replicated regions where such failure leads to the formation of FANCD2-flanking fragile site-UFBs (FS-UFBs) between the segregating chromatids (<xref ref-type="bibr" rid="bib63">Naim et al., 2013</xref>; <xref ref-type="bibr" rid="bib96">Ying et al., 2013</xref>). However, the frequent occurrence of breaks at corresponding locations on paired sister chromatids argues for a failure of DKO B cells to resolve HR intermediates. Visualization of UFBs in these cells hence may help delineate the molecular origins of these unique aberrations.</p><p>Detailed investigations into whether HR-UFBs derive predominantly from genomic loci where stalled replication forks are preferentially restarted through recombination-dependent mechanisms could provide mechanistic insights into the genomic instability of SSE-null B cells and clarify the manner by which GEN1 and MUS81 resolve replication stress—do they cleave persistent and late-occurring replication intermediates such as reversed forks or do they process HR intermediates (e.g., D-loops and HJs) arising from recombination-mediated restart of perturbed forks? Further studies to determine whether the loci where HR-UFBs manifest encompass early replication fragile sites (ERFSs) should be pursued given that ERFSs exhibit higher level of HR-dependent sister chromatid exchanges than CFSs upon chemical induction of replication stress (<xref ref-type="bibr" rid="bib89">Waisertreiger et al., 2020</xref>). More importantly, such sites have recently been identified as hotspots for transcription-replication conflicts and breakpoints of chromosomal rearrangements in B lymphocytes; hence, elucidating the molecular events involved in rectifying replication stress at ERFSs will be critical to better understanding the drivers of genomic instability (<xref ref-type="bibr" rid="bib3">Barlow et al., 2013</xref>).</p><p>The robust transcriptional upregulation of p53 signaling and apoptosis gene programs coupled with the de-enrichment of gene sets related to G2/M checkpoint progression, E2F targets, and MYC targets in activated DKO cells is consistent with the cell cycle and survival perturbations exhibited by these cells. Cellular stresses including DSBs trigger the p53 stress response that entails global transcriptional inhibition with activation of specific gene programs to induce metabolic rewiring, DNA damage repair, G1 and G2 arrests, apoptosis, and senescence (<xref ref-type="bibr" rid="bib46">Levine, 2020</xref>). Although the loss of GEN1 and MUS81 has not been directly linked to the downregulation of MYC signaling, the DNA damage response activated in the DKO cells causes the accumulation of p53 protein, resulting in elevated p53 binding to an enhancer element within a MYC super-enhancer and consequent repression of <italic>Myc</italic> mRNA transcription (<xref ref-type="bibr" rid="bib72">Porter et al., 2017</xref>). Moreover, p53 can directly impact the expression of <italic>Myc</italic> via other transcriptional and post-transcriptional mechanisms. p53 can activate the transcription of the long noncoding RNA <italic>Pvt1b</italic> to suppress in cis <italic>Myc</italic> transcription (<xref ref-type="bibr" rid="bib64">Olivero et al., 2020</xref>). miR-34 family and miR-145 are transcriptional targets of p53 and they contribute to the silencing of <italic>Myc</italic> expression by eliciting the degradation of Myc mRNA transcripts (<xref ref-type="bibr" rid="bib34">He et al., 2007</xref>; <xref ref-type="bibr" rid="bib76">Sachdeva et al., 2009</xref>). Other transcriptional targets of p53, including PTEN, TSC2, and AMPKβ, can impinge on MYC expression via their inhibition of the upstream regulator mTORC1 complex (<xref ref-type="bibr" rid="bib13">Cui et al., 2021</xref>; <xref ref-type="bibr" rid="bib46">Levine, 2020</xref>). These MYC-counteracting mechanisms are crucial to the proper enforcement of p53-induced cell cycle arrest and apoptosis. Our genetic study showed that the loss of p53 was insufficient to rescue the abrogated GC response and proliferative expansion of DKO B cells. Though p53 deletion did prevent apoptosis of ex vivo-activated DKO B cells early on, this survival benefit was only temporary as the p53-null DKO B cells experienced much higher level of cell death at later time points. We infer that the absence of p53 precludes the DKO p53-KO cells from arresting their cell cycle despite incurring extensive replication-associated DNA damage, leading to mitotic catastrophe and their eventual demise.</p><p>Our study presents the first evidence that the ablation of both GEN1 and MUS81 induces the expression of interferon-stimulated genes (ISGs), most likely attributed to the elevated levels of micronuclei in the DKO cells (<xref ref-type="bibr" rid="bib77">Sarbajna et al., 2014</xref>). Primary human fibroblast cells lacking the BLM dissolvase exhibit an enhanced ISG gene expression signature due to the increased level of cytoplasmic DNA and cGAS-positive micronuclei in these cells, suggesting a common transcriptional outcome in cells that fail to eliminate recombination-associated structures (<xref ref-type="bibr" rid="bib28">Gratia et al., 2019</xref>). Micronuclei are formed when chromosomal fragments or lagging chromosomes—manifestations of mitotic or DNA repair defects—become enveloped in a rupture-prone nuclear membrane after failing to be incorporated into the nucleus after mitosis (<xref ref-type="bibr" rid="bib59">Miller et al., 2021</xref>). Recognition of the micronuclei by cyclic GMP-AMP synthase (cGAS) triggers the catalytic production of the second messenger cyclic 2′3′-GMP-AMP (2′3′-cGAMP), promoting the phosphorylation of the adaptor stimulator of interferon genes (STING) that mediates the activation of interferon-regulatory factor 3 (IRF3) to drive the transcription of ISGs (<xref ref-type="bibr" rid="bib32">Harding et al., 2017</xref>; <xref ref-type="bibr" rid="bib47">Li and Chen, 2018</xref>; <xref ref-type="bibr" rid="bib53">Mackenzie et al., 2017</xref>). Production and release of chromatin fragments from spontaneously ruptured micronuclei and from improper degradation of nascent DNA at unprotected, stalled replication forks further contribute to the cytosolic pool of immunostimulatory DNA fragments (<xref ref-type="bibr" rid="bib12">Coquel et al., 2018</xref>; <xref ref-type="bibr" rid="bib18">Dou et al., 2017</xref>; <xref ref-type="bibr" rid="bib19">Emam et al., 2022</xref>; <xref ref-type="bibr" rid="bib27">Glück et al., 2017</xref>; <xref ref-type="bibr" rid="bib73">Ragu et al., 2020</xref>). DNA-stimulated type I IFN signaling, besides promoting the synthesis and secretion of proinflammatory cytokines, triggers various cell death programs including apoptosis, necroptosis, and autophagic cell death (<xref ref-type="bibr" rid="bib66">Paludan et al., 2019</xref>). Recent evidence in T cells, however, suggests that p53 signaling can be directly activated by STING via cyclic dinucleotides to trigger cell cycle arrest and apoptosis independent of type I IFN production (<xref ref-type="bibr" rid="bib11">Concepcion et al., 2022</xref>). We speculate that the cytoplasm of the DKO B cells could accumulate a panoply of self-DNA materials that fosters the production of 2′3-cGAMP and type I IFNs, initiating multiple cell death pathways simultaneously. This raises the question as to whether the cGAS-STING cascade comprises a secondary cell death signaling axis in the SSE-null cells, and whether micronucleated DKO B cells could elicit cell death in neighboring cells through the paracrine release of 2′3′-cGAMP and type I IFNs, given that macrophages and T cells can import 2′3′-cGAMP via the heteromeric anion channels LRRC8A-LRRC8E and LRRC8A-LRRC8C, respectively, to activate STING and type I IFN production (<xref ref-type="bibr" rid="bib11">Concepcion et al., 2022</xref>; <xref ref-type="bibr" rid="bib99">Zhou et al., 2020</xref>). Future studies examining the impact of cGAS or STING inhibition on the viability DKO B cells will be warranted to assess the role of these factors in DNA-stimulated intrinsic and extrinsic cell death pathways.</p><p>We posit that the illegitimate processing of branched DNA structures and the persistence of unresolved HR intermediates generated following replication fork stalling and recombination-mediated fork restart in proliferating B cells lacking GEN1 and MUS81 lead to the manifestation of aberrant mitotic structures including chromatin bridges, HR-UFBs, and micronuclei that enable rampant fusions of broken chromosomes and amplification of replication-derived DNA damage during the next cell cycle. Our studies show that such extensive chromosomal instability and genomic damage consequently activate p53-dependent G2/M arrest and apoptosis. Concurrently, these endonuclease-deficient B cells exhibit a type I IFN transcriptional signature, potentially a ramification of high levels of cytoplasmic self-DNA. The synthetic lethality of GEN1 and MUS81 deficiencies in B cells highlights the essentiality of SSEs in eliminating branched and joint DNA intermediates formed during replication, recombination, and repair events to safeguard the genomic integrity of proliferating cells and to confer the proliferative and survival capacities required for the proper development and functionality of B lymphocytes, and possibly other immune cells.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Mice</title><p><italic>Gen1</italic><sup>−/−</sup> mice were generated at the Memorial Sloan Kettering Cancer Center Mouse Genetics Core Facility. <italic>Mus81</italic><sup>fl/fl</sup> mice were generated using ES cell clone purchased from EUCOMM (<xref ref-type="bibr" rid="bib83">Skarnes et al., 2011</xref>). <italic>Mb1</italic> (<italic>Cd79a</italic>)-Cre mice were purchased from The Jackson Laboratory (strain #:020505) (<xref ref-type="bibr" rid="bib37">Hobeika et al., 2006</xref>). <italic>Cd23</italic>-Cre (<xref ref-type="bibr" rid="bib43">Kwon et al., 2008</xref>) and <italic>Aicda</italic><sup>−/−</sup> (<xref ref-type="bibr" rid="bib62">Muramatsu et al., 2000</xref>) mice were gifted by Meinrad Busslinger (Research Institute of Molecular Pathology, Austria) and Tasuku Honjo (University of Kyoto, Japan), respectively. <italic>Trp53</italic><sup>fl/fl</sup> mice were purchased from The Jackson Laboratory (strain #:008462) (<xref ref-type="bibr" rid="bib54">Marino et al., 2000</xref>). Experiments were performed using mice between 8- and 16-week-old. When littermate controls were unavailable, age-matched controls were employed in experiments. All mice were housed and maintained in groups of five under specific pathogen-free conditions, and euthanized at the time of analyses in accordance with guidelines for animal care established by Memorial Sloan Kettering Cancer Center Research Animal Resource Center and the Institutional Animal Care and Use Committee (IACUC).</p></sec><sec id="s4-2"><title>Flow cytometry and cell sorting</title><p>Single-cell suspensions were prepared from mouse spleen, mesenteric lymph nodes, and Peyer’s patches by pressing through a 70 μm cell strainer (Corning), and BM cells were harvested by flushing the tibia with B cell media (RPMI 1640 with L-glutamine (Gibco) supplemented with 15% fetal bovine serum (Corning), 1% penicillin-streptomycin (GeminiBio), 2 mM L-glutamine (Memorial Sloan Kettering Cancer Center Media Preparation Facility), and 55 μM β-Mercaptoethanol (Gibco)). Splenic and BM suspensions were resuspended in red blood cell lysis buffer (150 mM NH<sub>4</sub>Cl, 10 mM KHCO<sub>3</sub>, and 0.1 mM EDTA) for 5 min at room temperature and then neutralized with B cell media. After washing with Ca<sup>2+</sup>- and Mg<sup>2+</sup>-free phosphate-buffered saline (PBS), cells were stained with Zombie Red fixable viability dye (BioLegend) and rat anti-mouse CD16/CD32 Fc Block (BD Biosciences) at room temperature for 15 min in the dark, followed by staining with antibodies for cell surface markers at 4°C for 30 min in the dark. The following antibodies and their respective clones were used in this study: B220 (RA3-6B2), CD19 (ID3), TCRβ (H57-597), CD43 (R2/60), IgD (11.26.2a), IgM (II/41; polyclonal), CD25 (PC61), CD249 (BP-1), c-Kit (2B8), CD93 (AA4.1), CD24 (M1/69), CD138 (281-2), CD21/CD35 (7E9), CD23 (B3B4), GL7 (GL7), CD95 (Jo2), CD38 (90), IgG1 (X56), IgG3 (R40-82), and IgA (mA-6E1). For the sorting of pro-B (fractions B+C) cells, the antibodies used for the dump channel were TCRb (H57-597), Cd11b (M1/70), Ter-119 (TER-119), NK1.1 (PK136), and Gr1 (RB6-8C5). All antibodies were purchased from BD Biosciences, eBioscience, and BioLegend. For intracellular cleaved caspase-3 staining, ex vivo-stimulated cells were incubated in Zombie Red fixable viability dye and rat anti-mouse CD16/CD32 Fc Block, stained with antibodies for cell surface antigens, followed by staining with anti-cleaved caspase-3 antibody (C92-605; BD Biosciences) for 45 min at 4°C after processing with Fixation/Permeabilization kit (BD Biosciences) according to the manufacturer’s protocol. Data were obtained using an LSR II flow cytometer (BD Biosciences) and analyzed with FlowJo 10.6 (BD Biosciences). Pro-B (fractions B+C), GC, and non-GC B cells were sorted using a BD FACS Aria II (BD Biosciences).</p></sec><sec id="s4-3"><title>Immunization</title><p>For SRBC immunization, packed SRBCs (Innovative Research) were washed three times with PBS, counted with hemocytometer, and resuspended to a concentration of 10 million cells/μl. About 500 million cells were then administered intraperitoneally. Mice were boosted with the same number of SRBCs on day 10 before spleens were harvested for analysis on day 14. For NP-CGG immunization, mice were injected intraperitoneally with 100 μg NP-CGG (ratio 30–39; Biosearch Technologies) resuspended in Imject Alum adjuvant (Thermo Fisher Scientific). Mice were boosted on day 14 and euthanized on day 21 for analysis of immune response in the spleen.</p></sec><sec id="s4-4"><title>Primary B cell ex vivo stimulation</title><p>Splenic B cells were harvested and processed into single-cell suspensions by pressing through a 70 μm cell strainer. Naïve B cells were then purified by negative selection using anti-CD43 microbeads (Miltenyi Biotec) according to the manufacturer’s protocol. B cells were plated at a density of 1×10<sup>6</sup> cells/ml in B cell media in a six-well dish. B cells were then stimulated with one of the following cytokine cocktails: 33 μg/ml LPS (Sigma-Aldrich); 33 μg/ml LPS plus 25 ng/ml IL-4 (R&amp;D Systems); or 5 μg/ml LPS, 2 ng/ml recombinant human TGF-β1 (R&amp;D Systems), and 333 ng/ml anti-IgD dextran conjugates (Fina Biosolutions). Cultures were split by half at 48- and 72-hr post-stimulation.</p></sec><sec id="s4-5"><title>RT-qPCR</title><p>Total RNA was harvested from ex vivo B cell cultures, sorted pro-B (fractions B+C), and sorted GC and non-GC B cells using Quick-RNA Microprep Kit (ZymoResearch), Arcturus PicoPure RNA Extraction Kit (Thermo Fisher Scientific), and AllPrep DNA/RNA Micro Kit (QIAGEN), respectively, and subsequently reverse transcribed to cDNA using High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems). TaqMan probes specific for <italic>Gen1</italic> (Mm00724023_m1), <italic>Mus81</italic> (Mm00472065_m1), and <italic>Ubc</italic> (Mm01201237_m1) were used to amplify the cDNA transcripts. qPCR experiments were performed with TaqMan Fast Advanced Master Mix (Applied Biosystems) in a 384-well format using an Applied Biosystems QuantStudio 6 Flex instrument. Relative gene expression was calculated using the 2<sup>−ΔΔCT</sup> method and normalized to <italic>Ubc</italic> expression.</p></sec><sec id="s4-6"><title>Genomic qPCR</title><p>Genomic DNA was isolated from sorted pro-B (fractions B+C) and from sorted GC and non-GC B cells using Arcturus PicoPure DNA Extraction Kit (Thermo Fisher Scientific) and AllPrep DNA/RNA Micro Kit (QIAGEN), respectively, according to the manufacturer’s protocol. Primer pairs targeting the <italic>Mus81</italic><sup>fl/fl</sup> allele (Fwd: 5′- <named-content content-type="sequence">CCGGAACCGAAGTTCCTATT</named-content>-3′ and Rev: 5′- <named-content content-type="sequence">GTACAAGAAAGCTGGGTCTAGATA</named-content>-3′) and <italic>Ubc</italic> (Fwd: 5′-<named-content content-type="sequence">AGTCGCCCGAGGTCACA</named-content>-3′ and Rev: 5′-<named-content content-type="sequence">CGTCTCTCTCACGGAGTT GTTT</named-content>-3′) were used to amplify the genomic DNA. Experiments were performed with PowerUp SYBR Green Master Mix (Applied Biosystems) in a 384-well format using an Applied Biosystems QuantStudio 6 Flex instrument. Relative copy number of the unrecombined <italic>Mus81</italic><sup>fl/fl</sup> allele was determined using the 2<sup>−ΔΔCT</sup> method and normalized to <italic>Ubc</italic> copy number.</p></sec><sec id="s4-7"><title>Proliferation analysis</title><p>Purified naïve splenic B cells were stained with 5 μM CellTrace Violet (Invitrogen) in PBS for 20 min at room temperature in the dark. Cells were washed with B cell media to quench the dye before resuspension in fresh B cell media and subsequent incubation for at least 10 min at 37°C. Equal labeling between the genotypes was verified by flow cytometry immediately after labeling. Cytokine cocktails were then added to the B cell cultures to initiate stimulation.</p></sec><sec id="s4-8"><title>Cell cycle analysis</title><p>Prior to flow cytometric analysis, ex vivo B cells were treated with 10 μM EdU for 1 hr. Cells were harvested and washed with PBS before staining with antibodies for surface proteins. Cells were then processed using Click-iT Plus EdU Alexa Fluor 488 Flow Cytometry Assay Kit (Invitrogen) according to the manufacturer’s protocol. Cells were subsequently stained with FxCycle Violet Stain (Invitrogen) for 30 min at room temperature in the dark before flow cytometry.</p></sec><sec id="s4-9"><title>RNA-sequencing library generation and analyses</title><p>B cells were cultured for 48 hr before total RNA was extracted using Quick-RNA Microprep Kit (ZymoResearch) and mRNA was isolated using the NEBNext Poly(A) mRNA Magnetic Isolation (New England BioLabs). Stranded Illumina libraries were prepared with Swift Rapid RNA Library Kit according to the manufacturer’s instructions (Swift Biosciences). Indexed libraries were sequenced on a HiSeq X Ten platform, and an average of 30 million 150 bp paired-end reads were generated for each sample (Novogene, Beijing, China). The resulting FastQ files were processed to remove adapters and low-quality reads using GATK v4.1.9.0 (<xref ref-type="bibr" rid="bib87">Van der Auwera et al., 2013</xref>). STAR v2.7.7a (<xref ref-type="bibr" rid="bib17">Dobin et al., 2013</xref>) aligned the reads to GRCm38.p6 and gencode vM25 (<xref ref-type="bibr" rid="bib23">Frankish et al., 2021</xref>), and GATK removed the duplicates. A count matrix was generated using featureCounts v2.0.1 (<xref ref-type="bibr" rid="bib48">Liao et al., 2014</xref>), and DESeq2 v1.30.1 (<xref ref-type="bibr" rid="bib50">Love et al., 2014</xref>) generated differential expression matrices. ggPlot2 v3.3.4 (<xref ref-type="bibr" rid="bib93">Wickham, 2016</xref>) was used for creating volcano plots, highlighting genes that fall in the designated areas (see text). fgsea v1.16.0 (<xref ref-type="bibr" rid="bib42">Korotkevich et al., 2021</xref>) and msigdb h.all.v7.4 (<xref ref-type="bibr" rid="bib49">Liberzon et al., 2015</xref>; <xref ref-type="bibr" rid="bib85">Subramanian et al., 2005</xref>) analyzed the differentially expressed genes (those with FDR&lt;0.05) in DKO cells compared to control cells to determine which gene sets were enriched and de-enriched. Then, ggplot2 and a modified fgsea script was used to generate GSEA plots. Finally, the feature count matrix was also used to produce normalized TPM values for all genes in each sample; these were then plotted with ComplexHeatmap v2.6.2 (<xref ref-type="bibr" rid="bib29">Gu et al., 2016</xref>). All scripts are deposited in <ext-link ext-link-type="uri" xlink:href="https://github.com/ryashka/RNA_Seq_MusGen">GitHub</ext-link> (copy archived at <xref ref-type="bibr" rid="bib84">Smolkin, 2022</xref>). For the analysis of GSE720181, the data set was downloaded as a featureCounts matrix and converted to TPM values in R v4.0.5.</p></sec><sec id="s4-10"><title>Metaphase spreads</title><p>Metaphase chromosome spreads were prepared by incubating cells with 100 μg/ml KaryoMAX Colcemid Solution in PBS (Gibco) for 3 hr. Cells were harvested at 1000 rpm and resuspended in 75 mM KCl at 37°C for 15 min. Cells were fixed in a 3:1 mixture of ice-cold methanol/acetic acid at least overnight at –20°C. Samples were then dropped onto pre-cleaned slides, briefly steamed (&lt;5 s) over an 80°C water bath to disperse nuclei and air-dried overnight at room temperature. Slides were stained in Giemsa solution and mounted using Fisher Chemical Permount Mounting Medium (Thermo Fisher Scientific). Images were acquired on an Olympus IX50-S8F microscope using a 100× objective and images were analyzed using ImageJ.</p></sec><sec id="s4-11"><title>Telomere FISH</title><p>Metaphase chromosome spreads were prepared and dropped onto slides as described above. Instead of Giemsa staining, samples were treated with 100 μg/ml RNAse A for 1 hr at 37°C, dehydrated with a series of 70%, 90%, and 100% ethanol for 5 min each at room temperature, then allowed to air dry. Hybridization with 0.5 μg/ml CY-3 (CCCTAA)<sub>3</sub> probe (PNA Bio) was carried out in hybridization buffer (10 mM Tris pH 7.5, 70% formamide, 0.5% blocking reagent (Roche)). Samples were denatured at 75°C for 5 min and hybridization was then allowed to proceed at room temperature for 16 hr. Slides were washed two times in wash buffer (10 mM Tris pH 7.5, 0.1% BSA, and 70% formamide) and then three times in PBS/0.15% Triton X. Slides were subsequently incubated for 10 min at room temperature in SYTOX Green Nucleic Acid Stain (diluted to 0.5 mM in PBS). After a final PBS wash, slides were mounted with ProLong Gold Antifade Mountant with DAPI (Invitrogen). Images were acquired on a DeltaVision Elite Cell Imaging System (GE Healthcare Life Sciences) with a CMOS Camera on an Olympus IX-71 microscope using a 60× objective. Images were analyzed using ImageJ.</p></sec><sec id="s4-12"><title>Statistical analysis</title><p>Graphical representation of data and statistical analyses were performed using Prism 9 (GraphPad Software). Tables were prepared using Numbers 11 (Apple).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Visualization, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con3"><p>Software, Formal analysis, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Resources, Supervision, Funding acquisition, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Resources, Supervision, Funding acquisition, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All mice were housed and maintained in groups of five under specific pathogen-free conditions, and euthanized at the time of analyses in accordance with guidelines for animal care established by Memorial Sloan Kettering Cancer Center Research Animal Resource Center and the Institutional Animal Care and Use Committee (IACUC). All mouse experimentation protocols were approved by MSK's IACUC (Protocol Number: 05-12-030).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-77073-transrepform1-v5.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The RNAseq data and analysis generated in this study are deposited in GEO under the accession code GSE195734. The Gen1 and Mus81 expression data in the various B cell subsets was previously generated by Brazão et al. (2016) and deposited under GSE72018 in GEO.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>K</given-names></name><name><surname>Smolkin</surname><given-names>R</given-names></name><name><surname>Chaudhuri</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>mRNA sequencing of control and resolvase-deficient ex vivo-stimulated B cells</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE195734">GSE195734</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Brazão</surname><given-names>TF</given-names></name><name><surname>Johnson</surname><given-names>JS</given-names></name><name><surname>Müller</surname><given-names>J</given-names></name><name><surname>Heger</surname><given-names>A</given-names></name><name><surname>Ponting</surname><given-names>CP</given-names></name><name><surname>Tybulewicz</surname><given-names>VLJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>Long non-coding RNAs in B cells (RNA-Seq)</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72018">GSE72018</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>The authors would like to thank the past and present members of the Chaudhuri and the Petrini labs for technical assistance, productive discussions, and constructive feedback. The authors specifically thank Youngjun Kim for experimental contributions. JC was supported by grants from the NIH (R01AI072194, R01AI124186, R56AI072194, U54CA137788, and P30CA008748), the Starr Cancer Research Foundation, the Ludwig Center for Cancer Immunotherapy, MSKCC Functional Genomics, and the Geoffrey Beene Cancer Center. JHJP was supported by grants from the NIH (R01GM56888, R35GM136278, U54OD020355, and P30CA008748). The authors thank Antonio Bravo for help with maintenance of the mouse colony. The authors acknowledge the use of the Memorial Sloan Kettering Cancer Mouse Genetics Core Facility.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ait Saada</surname><given-names>A</given-names></name><name><surname>Lambert</surname><given-names>SAE</given-names></name><name><surname>Carr</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Preserving replication fork integrity and competence via the homologous recombination pathway</article-title><source>DNA Repair</source><volume>71</volume><fpage>135</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1016/j.dnarep.2018.08.017</pub-id><pub-id pub-id-type="pmid">30220600</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alt</surname><given-names>FW</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Meng</surname><given-names>FL</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Schwer</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mechanisms of programmed DNA lesions and genomic instability in the immune system</article-title><source>Cell</source><volume>152</volume><fpage>417</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.01.007</pub-id><pub-id pub-id-type="pmid">23374339</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barlow</surname><given-names>JH</given-names></name><name><surname>Faryabi</surname><given-names>RB</given-names></name><name><surname>Callén</surname><given-names>E</given-names></name><name><surname>Wong</surname><given-names>N</given-names></name><name><surname>Malhowski</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>HT</given-names></name><name><surname>Gutierrez-Cruz</surname><given-names>G</given-names></name><name><surname>Sun</surname><given-names>HW</given-names></name><name><surname>McKinnon</surname><given-names>P</given-names></name><name><surname>Wright</surname><given-names>G</given-names></name><name><surname>Casellas</surname><given-names>R</given-names></name><name><surname>Robbiani</surname><given-names>DF</given-names></name><name><surname>Staudt</surname><given-names>L</given-names></name><name><surname>Fernandez-Capetillo</surname><given-names>O</given-names></name><name><surname>Nussenzweig</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Identification of early replicating fragile sites that contribute to genome instability</article-title><source>Cell</source><volume>152</volume><fpage>620</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.01.006</pub-id><pub-id pub-id-type="pmid">23352430</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basso</surname><given-names>K</given-names></name><name><surname>Dalla-Favera</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Germinal centres and B cell lymphomagenesis</article-title><source>Nature Reviews Immunology</source><volume>15</volume><fpage>172</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1038/nri3814</pub-id><pub-id pub-id-type="pmid">25712152</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berti</surname><given-names>M</given-names></name><name><surname>Cortez</surname><given-names>D</given-names></name><name><surname>Lopes</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The plasticity of DNA replication forks in response to clinically relevant genotoxic stress</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>21</volume><fpage>633</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1038/s41580-020-0257-5</pub-id><pub-id pub-id-type="pmid">32612242</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco</surname><given-names>MG</given-names></name><name><surname>Matos</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Hold your horSSEs: controlling structure-selective endonucleases MUS81 and Yen1/GEN1</article-title><source>Frontiers in Genetics</source><volume>6</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.3389/fgene.2015.00253</pub-id><pub-id pub-id-type="pmid">26284109</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brazão</surname><given-names>TF</given-names></name><name><surname>Johnson</surname><given-names>JS</given-names></name><name><surname>Müller</surname><given-names>J</given-names></name><name><surname>Heger</surname><given-names>A</given-names></name><name><surname>Ponting</surname><given-names>CP</given-names></name><name><surname>Tybulewicz</surname><given-names>VLJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Long noncoding RNAs in B-cell development and activation</article-title><source>Blood</source><volume>128</volume><elocation-id>e10</elocation-id><pub-id pub-id-type="doi">10.1182/blood-2015-11-680843</pub-id><pub-id pub-id-type="pmid">27381906</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carr</surname><given-names>AM</given-names></name><name><surname>Lambert</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Replication stress-induced genome instability: the dark side of replication maintenance by homologous recombination</article-title><source>Journal of Molecular Biology</source><volume>425</volume><fpage>4733</fpage><lpage>4744</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2013.04.023</pub-id><pub-id pub-id-type="pmid">23643490</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>YW</given-names></name><name><surname>Fugger</surname><given-names>K</given-names></name><name><surname>West</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Unresolved recombination intermediates lead to ultra-fine anaphase bridges, chromosome breaks and aberrations</article-title><source>Nature Cell Biology</source><volume>20</volume><fpage>92</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1038/s41556-017-0011-1</pub-id><pub-id pub-id-type="pmid">29255170</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>YW</given-names></name><name><surname>West</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A new class of ultrafine anaphase bridges generated by homologous recombination</article-title><source>Cell Cycle</source><volume>17</volume><fpage>2101</fpage><lpage>2109</lpage><pub-id pub-id-type="doi">10.1080/15384101.2018.1515555</pub-id><pub-id pub-id-type="pmid">30253678</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Concepcion</surname><given-names>AR</given-names></name><name><surname>Wagner</surname><given-names>LE</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Tao</surname><given-names>AY</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Khodadadi-Jamayran</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>YH</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Rose</surname><given-names>RE</given-names></name><name><surname>Jones</surname><given-names>DR</given-names></name><name><surname>Coetzee</surname><given-names>WA</given-names></name><name><surname>Yule</surname><given-names>DI</given-names></name><name><surname>Feske</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The volume-regulated anion channel LRRC8C suppresses T cell function by regulating cyclic dinucleotide transport and STING-p53 signaling</article-title><source>Nature Immunology</source><volume>23</volume><fpage>287</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1038/s41590-021-01105-x</pub-id><pub-id pub-id-type="pmid">35105987</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coquel</surname><given-names>F</given-names></name><name><surname>Silva</surname><given-names>MJ</given-names></name><name><surname>Técher</surname><given-names>H</given-names></name><name><surname>Zadorozhny</surname><given-names>K</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Nieminuszczy</surname><given-names>J</given-names></name><name><surname>Mettling</surname><given-names>C</given-names></name><name><surname>Dardillac</surname><given-names>E</given-names></name><name><surname>Barthe</surname><given-names>A</given-names></name><name><surname>Schmitz</surname><given-names>AL</given-names></name><name><surname>Promonet</surname><given-names>A</given-names></name><name><surname>Cribier</surname><given-names>A</given-names></name><name><surname>Sarrazin</surname><given-names>A</given-names></name><name><surname>Niedzwiedz</surname><given-names>W</given-names></name><name><surname>Lopez</surname><given-names>B</given-names></name><name><surname>Costanzo</surname><given-names>V</given-names></name><name><surname>Krejci</surname><given-names>L</given-names></name><name><surname>Chabes</surname><given-names>A</given-names></name><name><surname>Benkirane</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>YL</given-names></name><name><surname>Pasero</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>SAMHD1 acts at stalled replication forks to prevent interferon induction</article-title><source>Nature</source><volume>557</volume><fpage>57</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0050-1</pub-id><pub-id pub-id-type="pmid">29670289</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>D</given-names></name><name><surname>Qu</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Xiong</surname><given-names>X</given-names></name><name><surname>Liang</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The cross talk between p53 and mTOR pathways in response to physiological and genotoxic stresses</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>9</volume><elocation-id>775507</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2021.775507</pub-id><pub-id pub-id-type="pmid">34869377</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debatisse</surname><given-names>M</given-names></name><name><surname>Le Tallec</surname><given-names>B</given-names></name><name><surname>Letessier</surname><given-names>A</given-names></name><name><surname>Dutrillaux</surname><given-names>B</given-names></name><name><surname>Brison</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Common fragile sites: mechanisms of instability revisited</article-title><source>Trends in Genetics</source><volume>28</volume><fpage>22</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2011.10.003</pub-id><pub-id pub-id-type="pmid">22094264</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dehé</surname><given-names>PM</given-names></name><name><surname>Gaillard</surname><given-names>PHL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Control of structure-specific endonucleases to maintain genome stability</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>18</volume><fpage>315</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1038/nrm.2016.177</pub-id><pub-id pub-id-type="pmid">28327556</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dendouga</surname><given-names>N</given-names></name><name><surname>Gao</surname><given-names>H</given-names></name><name><surname>Moechars</surname><given-names>D</given-names></name><name><surname>Janicot</surname><given-names>M</given-names></name><name><surname>Vialard</surname><given-names>J</given-names></name><name><surname>McGowan</surname><given-names>CH</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Disruption of murine Mus81 increases genomic instability and DNA damage sensitivity but does not promote tumorigenesis</article-title><source>Molecular and Cellular Biology</source><volume>25</volume><fpage>7569</fpage><lpage>7579</lpage><pub-id pub-id-type="doi">10.1128/MCB.25.17.7569-7579.2005</pub-id><pub-id pub-id-type="pmid">16107704</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dou</surname><given-names>Z</given-names></name><name><surname>Ghosh</surname><given-names>K</given-names></name><name><surname>Vizioli</surname><given-names>MG</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Sen</surname><given-names>P</given-names></name><name><surname>Wangensteen</surname><given-names>KJ</given-names></name><name><surname>Simithy</surname><given-names>J</given-names></name><name><surname>Lan</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Capell</surname><given-names>BC</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Kieckhaefer</surname><given-names>JE</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Shoshkes-Carmel</surname><given-names>M</given-names></name><name><surname>Tanim</surname><given-names>KMAA</given-names></name><name><surname>Barber</surname><given-names>GN</given-names></name><name><surname>Seykora</surname><given-names>JT</given-names></name><name><surname>Millar</surname><given-names>SE</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name><name><surname>Garcia</surname><given-names>BA</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Berger</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cytoplasmic chromatin triggers inflammation in senescence and cancer</article-title><source>Nature</source><volume>550</volume><fpage>402</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1038/nature24050</pub-id><pub-id pub-id-type="pmid">28976970</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emam</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Stalled replication fork protection limits cGAS-STING and P-body-dependent innate immune signalling</article-title><source>Nature Cell Biology</source><volume>24</volume><fpage>1154</fpage><lpage>1164</lpage><pub-id pub-id-type="doi">10.1038/s41556-022-00950-8</pub-id><pub-id pub-id-type="pmid">35817959</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fahl</surname><given-names>SP</given-names></name><name><surname>Crittenden</surname><given-names>RB</given-names></name><name><surname>Allman</surname><given-names>D</given-names></name><name><surname>Bender</surname><given-names>TP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>c-Myb is required for pro-B cell differentiation</article-title><source>Journal of Immunology</source><volume>183</volume><fpage>5582</fpage><lpage>5592</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0901187</pub-id><pub-id pub-id-type="pmid">19843942</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falquet</surname><given-names>B</given-names></name><name><surname>Rass</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Structure-specific endonucleases and the resolution of chromosome underreplication</article-title><source>Genes</source><volume>10</volume><fpage>1</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.3390/genes10030232</pub-id><pub-id pub-id-type="pmid">30893921</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Seija</surname><given-names>N</given-names></name><name><surname>Di Noia</surname><given-names>JM</given-names></name><name><surname>Martin</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>AID in antibody diversification: there and back again</article-title><source>Trends in Immunology</source><volume>41</volume><fpage>586</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1016/j.it.2020.04.009</pub-id><pub-id pub-id-type="pmid">32434680</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frankish</surname><given-names>A</given-names></name><name><surname>Diekhans</surname><given-names>M</given-names></name><name><surname>Jungreis</surname><given-names>I</given-names></name><name><surname>Lagarde</surname><given-names>J</given-names></name><name><surname>Loveland</surname><given-names>JE</given-names></name><name><surname>Mudge</surname><given-names>JM</given-names></name><name><surname>Sisu</surname><given-names>C</given-names></name><name><surname>Wright</surname><given-names>JC</given-names></name><name><surname>Armstrong</surname><given-names>J</given-names></name><name><surname>Barnes</surname><given-names>I</given-names></name><name><surname>Berry</surname><given-names>A</given-names></name><name><surname>Bignell</surname><given-names>A</given-names></name><name><surname>Boix</surname><given-names>C</given-names></name><name><surname>Carbonell Sala</surname><given-names>S</given-names></name><name><surname>Cunningham</surname><given-names>F</given-names></name><name><surname>Di Domenico</surname><given-names>T</given-names></name><name><surname>Donaldson</surname><given-names>S</given-names></name><name><surname>Fiddes</surname><given-names>IT</given-names></name><name><surname>García Girón</surname><given-names>C</given-names></name><name><surname>Gonzalez</surname><given-names>JM</given-names></name><name><surname>Grego</surname><given-names>T</given-names></name><name><surname>Hardy</surname><given-names>M</given-names></name><name><surname>Hourlier</surname><given-names>T</given-names></name><name><surname>Howe</surname><given-names>KL</given-names></name><name><surname>Hunt</surname><given-names>T</given-names></name><name><surname>Izuogu</surname><given-names>OG</given-names></name><name><surname>Johnson</surname><given-names>R</given-names></name><name><surname>Martin</surname><given-names>FJ</given-names></name><name><surname>Martínez</surname><given-names>L</given-names></name><name><surname>Mohanan</surname><given-names>S</given-names></name><name><surname>Muir</surname><given-names>P</given-names></name><name><surname>Navarro</surname><given-names>FCP</given-names></name><name><surname>Parker</surname><given-names>A</given-names></name><name><surname>Pei</surname><given-names>B</given-names></name><name><surname>Pozo</surname><given-names>F</given-names></name><name><surname>Riera</surname><given-names>FC</given-names></name><name><surname>Ruffier</surname><given-names>M</given-names></name><name><surname>Schmitt</surname><given-names>BM</given-names></name><name><surname>Stapleton</surname><given-names>E</given-names></name><name><surname>Suner</surname><given-names>M-M</given-names></name><name><surname>Sycheva</surname><given-names>I</given-names></name><name><surname>Uszczynska-Ratajczak</surname><given-names>B</given-names></name><name><surname>Wolf</surname><given-names>MY</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>YT</given-names></name><name><surname>Yates</surname><given-names>A</given-names></name><name><surname>Zerbino</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Choudhary</surname><given-names>JS</given-names></name><name><surname>Gerstein</surname><given-names>M</given-names></name><name><surname>Guigó</surname><given-names>R</given-names></name><name><surname>Hubbard</surname><given-names>TJP</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name><name><surname>Paten</surname><given-names>B</given-names></name><name><surname>Tress</surname><given-names>ML</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>GENCODE 2021</article-title><source>Nucleic Acids Research</source><volume>49</volume><fpage>D916</fpage><lpage>D923</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa1087</pub-id><pub-id pub-id-type="pmid">33270111</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname><given-names>M</given-names></name><name><surname>Sasanuma</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>KN</given-names></name><name><surname>Harada</surname><given-names>H</given-names></name><name><surname>Kurosawa</surname><given-names>A</given-names></name><name><surname>Adachi</surname><given-names>N</given-names></name><name><surname>Omura</surname><given-names>M</given-names></name><name><surname>Hiraoka</surname><given-names>M</given-names></name><name><surname>Takeda</surname><given-names>S</given-names></name><name><surname>Hirota</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Interference in DNA replication can cause mitotic chromosomal breakage unassociated with double-strand breaks</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e60043</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0060043</pub-id><pub-id pub-id-type="pmid">23573231</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-Luis</surname><given-names>J</given-names></name><name><surname>Machín</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mus81-Mms4 and Yen1 resolve a novel anaphase bridge formed by noncanonical Holliday junctions</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>5652</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms6652</pub-id><pub-id pub-id-type="pmid">25466415</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garner</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Lach</surname><given-names>FP</given-names></name><name><surname>Kottemann</surname><given-names>MC</given-names></name><name><surname>Smogorzewska</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Human GEN1 and the SLX4-associated nucleases MUS81 and SLX1 are essential for the resolution of replication-induced holliday junctions</article-title><source>Cell Reports</source><volume>5</volume><fpage>207</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.08.041</pub-id><pub-id pub-id-type="pmid">24080495</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glück</surname><given-names>S</given-names></name><name><surname>Guey</surname><given-names>B</given-names></name><name><surname>Gulen</surname><given-names>MF</given-names></name><name><surname>Wolter</surname><given-names>K</given-names></name><name><surname>Kang</surname><given-names>TW</given-names></name><name><surname>Schmacke</surname><given-names>NA</given-names></name><name><surname>Bridgeman</surname><given-names>A</given-names></name><name><surname>Rehwinkel</surname><given-names>J</given-names></name><name><surname>Zender</surname><given-names>L</given-names></name><name><surname>Ablasser</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence</article-title><source>Nature Cell Biology</source><volume>19</volume><fpage>1061</fpage><lpage>1070</lpage><pub-id pub-id-type="doi">10.1038/ncb3586</pub-id><pub-id pub-id-type="pmid">28759028</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gratia</surname><given-names>M</given-names></name><name><surname>Rodero</surname><given-names>MP</given-names></name><name><surname>Conrad</surname><given-names>C</given-names></name><name><surname>Bou Samra</surname><given-names>E</given-names></name><name><surname>Maurin</surname><given-names>M</given-names></name><name><surname>Rice</surname><given-names>GI</given-names></name><name><surname>Duffy</surname><given-names>D</given-names></name><name><surname>Revy</surname><given-names>P</given-names></name><name><surname>Petit</surname><given-names>F</given-names></name><name><surname>Dale</surname><given-names>RC</given-names></name><name><surname>Crow</surname><given-names>YJ</given-names></name><name><surname>Amor-Gueret</surname><given-names>M</given-names></name><name><surname>Manel</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Bloom syndrome protein restrains innate immune sensing of micronuclei by cGAS</article-title><source>The Journal of Experimental Medicine</source><volume>216</volume><fpage>1199</fpage><lpage>1213</lpage><pub-id pub-id-type="doi">10.1084/jem.20181329</pub-id><pub-id pub-id-type="pmid">30936263</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>Z</given-names></name><name><surname>Eils</surname><given-names>R</given-names></name><name><surname>Schlesner</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Complex heatmaps reveal patterns and correlations in multidimensional genomic data</article-title><source>Bioinformatics</source><volume>32</volume><fpage>2847</fpage><lpage>2849</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btw313</pub-id><pub-id pub-id-type="pmid">27207943</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanada</surname><given-names>K</given-names></name><name><surname>Budzowska</surname><given-names>M</given-names></name><name><surname>Davies</surname><given-names>SL</given-names></name><name><surname>van Drunen</surname><given-names>E</given-names></name><name><surname>Onizawa</surname><given-names>H</given-names></name><name><surname>Beverloo</surname><given-names>HB</given-names></name><name><surname>Maas</surname><given-names>A</given-names></name><name><surname>Essers</surname><given-names>J</given-names></name><name><surname>Hickson</surname><given-names>ID</given-names></name><name><surname>Kanaar</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The structure-specific endonuclease Mus81 contributes to replication restart by generating double-strand DNA breaks</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>14</volume><fpage>1096</fpage><lpage>1104</lpage><pub-id pub-id-type="doi">10.1038/nsmb1313</pub-id><pub-id pub-id-type="pmid">17934473</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Z</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow</article-title><source>The Journal of Experimental Medicine</source><volume>194</volume><fpage>1151</fpage><lpage>1164</lpage><pub-id pub-id-type="doi">10.1084/jem.194.8.1151</pub-id><pub-id pub-id-type="pmid">11602643</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harding</surname><given-names>SM</given-names></name><name><surname>Benci</surname><given-names>JL</given-names></name><name><surname>Irianto</surname><given-names>J</given-names></name><name><surname>Discher</surname><given-names>DE</given-names></name><name><surname>Minn</surname><given-names>AJ</given-names></name><name><surname>Greenberg</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mitotic progression following DNA damage enables pattern recognition within micronuclei</article-title><source>Nature</source><volume>548</volume><fpage>466</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1038/nature23470</pub-id><pub-id pub-id-type="pmid">28759889</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>RR</given-names></name><name><surname>Carmack</surname><given-names>CE</given-names></name><name><surname>Shinton</surname><given-names>SA</given-names></name><name><surname>Kemp</surname><given-names>JD</given-names></name><name><surname>Hayakawa</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow</article-title><source>The Journal of Experimental Medicine</source><volume>173</volume><fpage>1213</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1084/jem.173.5.1213</pub-id><pub-id pub-id-type="pmid">1827140</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Lim</surname><given-names>LP</given-names></name><name><surname>de Stanchina</surname><given-names>E</given-names></name><name><surname>Xuan</surname><given-names>Z</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Xue</surname><given-names>W</given-names></name><name><surname>Zender</surname><given-names>L</given-names></name><name><surname>Magnus</surname><given-names>J</given-names></name><name><surname>Ridzon</surname><given-names>D</given-names></name><name><surname>Jackson</surname><given-names>AL</given-names></name><name><surname>Linsley</surname><given-names>PS</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Lowe</surname><given-names>SW</given-names></name><name><surname>Cleary</surname><given-names>MA</given-names></name><name><surname>Hannon</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A microRNA component of the p53 tumour suppressor network</article-title><source>Nature</source><volume>447</volume><fpage>1130</fpage><lpage>1134</lpage><pub-id pub-id-type="doi">10.1038/nature05939</pub-id><pub-id pub-id-type="pmid">17554337</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heyer</surname><given-names>WD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Regulation of recombination and genomic maintenance</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>7</volume><elocation-id>a016501</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a016501</pub-id><pub-id pub-id-type="pmid">26238353</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>CK</given-names></name><name><surname>Mazón</surname><given-names>G</given-names></name><name><surname>Lam</surname><given-names>AF</given-names></name><name><surname>Symington</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mus81 and Yen1 promote reciprocal exchange during mitotic recombination to maintain genome integrity in budding yeast</article-title><source>Molecular Cell</source><volume>40</volume><fpage>988</fpage><lpage>1000</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.11.016</pub-id><pub-id pub-id-type="pmid">21172663</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobeika</surname><given-names>E</given-names></name><name><surname>Thiemann</surname><given-names>S</given-names></name><name><surname>Storch</surname><given-names>B</given-names></name><name><surname>Jumaa</surname><given-names>H</given-names></name><name><surname>Nielsen</surname><given-names>PJ</given-names></name><name><surname>Pelanda</surname><given-names>R</given-names></name><name><surname>Reth</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Testing gene function early in the B cell lineage in mb1-cre mice</article-title><source>PNAS</source><volume>103</volume><fpage>13789</fpage><lpage>13794</lpage><pub-id pub-id-type="doi">10.1073/pnas.0605944103</pub-id><pub-id pub-id-type="pmid">16940357</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodgkin</surname><given-names>PD</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Lyons</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>B cell differentiation and isotype switching is related to division cycle number</article-title><source>The Journal of Experimental Medicine</source><volume>184</volume><fpage>277</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1084/jem.184.1.277</pub-id><pub-id pub-id-type="pmid">8691143</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollingsworth</surname><given-names>NM</given-names></name><name><surname>Brill</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The MUS81 solution to resolution: generating meiotic crossovers without Holliday junctions</article-title><source>Genes &amp; Development</source><volume>18</volume><fpage>117</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1101/gad.1165904</pub-id><pub-id pub-id-type="pmid">14752007</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname><given-names>Z</given-names></name><name><surname>Fang</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Luo</surname><given-names>Z</given-names></name><name><surname>Yuan</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Crystal structure of the human MUS81-EME2 complex</article-title><source>Structure</source><volume>30</volume><fpage>743</fpage><lpage>752</lpage><pub-id pub-id-type="doi">10.1016/j.str.2022.02.015</pub-id><pub-id pub-id-type="pmid">35290797</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikuchi</surname><given-names>K</given-names></name><name><surname>Narita</surname><given-names>T</given-names></name><name><surname>Pham</surname><given-names>VT</given-names></name><name><surname>Iijima</surname><given-names>J</given-names></name><name><surname>Hirota</surname><given-names>K</given-names></name><name><surname>Keka</surname><given-names>IS</given-names></name><name><surname>Okawa</surname><given-names>K</given-names></name><name><surname>Hori</surname><given-names>T</given-names></name><name><surname>Fukagawa</surname><given-names>T</given-names></name><name><surname>Essers</surname><given-names>J</given-names></name><name><surname>Kanaar</surname><given-names>R</given-names></name><name><surname>Whitby</surname><given-names>MC</given-names></name><name><surname>Sugasawa</surname><given-names>K</given-names></name><name><surname>Taniguchi</surname><given-names>Y</given-names></name><name><surname>Kitagawa</surname><given-names>K</given-names></name><name><surname>Takeda</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Structure-specific endonucleases Xpf and Mus81 play overlapping but essential roles in DNA repair by homologous recombination</article-title><source>Cancer Research</source><volume>73</volume><fpage>4362</fpage><lpage>4371</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-12-3154</pub-id><pub-id pub-id-type="pmid">23576554</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Korotkevich</surname><given-names>G</given-names></name><name><surname>Sukhov</surname><given-names>V</given-names></name><name><surname>Budin</surname><given-names>N</given-names></name><name><surname>Shpak</surname><given-names>B</given-names></name><name><surname>Artyomov</surname><given-names>MN</given-names></name><name><surname>Sergushichev</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Fast Gene Set Enrichment Analysis</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/060012</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>K</given-names></name><name><surname>Hutter</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Bilic</surname><given-names>I</given-names></name><name><surname>Cobaleda</surname><given-names>C</given-names></name><name><surname>Malin</surname><given-names>S</given-names></name><name><surname>Busslinger</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development</article-title><source>Immunity</source><volume>28</volume><fpage>751</fpage><lpage>762</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2008.04.014</pub-id><pub-id pub-id-type="pmid">18538592</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>S</given-names></name><name><surname>Mizuno</surname><given-names>K</given-names></name><name><surname>Blaisonneau</surname><given-names>J</given-names></name><name><surname>Martineau</surname><given-names>S</given-names></name><name><surname>Chanet</surname><given-names>R</given-names></name><name><surname>Fréon</surname><given-names>K</given-names></name><name><surname>Murray</surname><given-names>JM</given-names></name><name><surname>Carr</surname><given-names>AM</given-names></name><name><surname>Baldacci</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Homologous recombination restarts blocked replication forks at the expense of genome rearrangements by template exchange</article-title><source>Molecular Cell</source><volume>39</volume><fpage>346</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.07.015</pub-id><pub-id pub-id-type="pmid">20705238</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeBien</surname><given-names>TW</given-names></name><name><surname>Tedder</surname><given-names>TF</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>B lymphocytes: how they develop and function</article-title><source>Blood</source><volume>112</volume><fpage>1570</fpage><lpage>1580</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-02-078071</pub-id><pub-id pub-id-type="pmid">18725575</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>p53: 800 million years of evolution and 40 years of discovery</article-title><source>Nature Reviews Cancer</source><volume>20</volume><fpage>471</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1038/s41568-020-0262-1</pub-id><pub-id pub-id-type="pmid">32404993</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer</article-title><source>The Journal of Experimental Medicine</source><volume>215</volume><fpage>1287</fpage><lpage>1299</lpage><pub-id pub-id-type="doi">10.1084/jem.20180139</pub-id><pub-id pub-id-type="pmid">29622565</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title><source>Bioinformatics</source><volume>30</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id><pub-id pub-id-type="pmid">24227677</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liberzon</surname><given-names>A</given-names></name><name><surname>Birger</surname><given-names>C</given-names></name><name><surname>Thorvaldsdóttir</surname><given-names>H</given-names></name><name><surname>Ghandi</surname><given-names>M</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The molecular signatures database hallmark gene set collection</article-title><source>Cell Systems</source><volume>1</volume><fpage>417</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2015.12.004</pub-id><pub-id pub-id-type="pmid">26771021</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macheret</surname><given-names>M</given-names></name><name><surname>Halazonetis</surname><given-names>TD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>DNA replication stress as a hallmark of cancer</article-title><source>Annual Review of Pathology</source><volume>10</volume><fpage>425</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1146/annurev-pathol-012414-040424</pub-id><pub-id pub-id-type="pmid">25621662</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mackay</surname><given-names>F</given-names></name><name><surname>Gommerman</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2015">2015</year><chapter-title>The role of the BAFF and lymphotoxin pathways in B cell biology</chapter-title><source>Molecular Biology of B Cells</source><publisher-name>Elsevier</publisher-name><pub-id pub-id-type="doi">10.1016/B978-0-12-397933-9.00015-1</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackenzie</surname><given-names>KJ</given-names></name><name><surname>Carroll</surname><given-names>P</given-names></name><name><surname>Martin</surname><given-names>CA</given-names></name><name><surname>Murina</surname><given-names>O</given-names></name><name><surname>Fluteau</surname><given-names>A</given-names></name><name><surname>Simpson</surname><given-names>DJ</given-names></name><name><surname>Olova</surname><given-names>N</given-names></name><name><surname>Sutcliffe</surname><given-names>H</given-names></name><name><surname>Rainger</surname><given-names>JK</given-names></name><name><surname>Leitch</surname><given-names>A</given-names></name><name><surname>Osborn</surname><given-names>RT</given-names></name><name><surname>Wheeler</surname><given-names>AP</given-names></name><name><surname>Nowotny</surname><given-names>M</given-names></name><name><surname>Gilbert</surname><given-names>N</given-names></name><name><surname>Chandra</surname><given-names>T</given-names></name><name><surname>Reijns</surname><given-names>MAM</given-names></name><name><surname>Jackson</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>cGAS surveillance of micronuclei links genome instability to innate immunity</article-title><source>Nature</source><volume>548</volume><fpage>461</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1038/nature23449</pub-id><pub-id pub-id-type="pmid">28738408</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marino</surname><given-names>S</given-names></name><name><surname>Vooijs</surname><given-names>M</given-names></name><name><surname>van der Gulden</surname><given-names>H</given-names></name><name><surname>Jonkers</surname><given-names>J</given-names></name><name><surname>Berns</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum</article-title><source>Genes &amp; Development</source><volume>14</volume><fpage>994</fpage><lpage>1004</lpage><pub-id pub-id-type="doi">10.1101/gad.14.8.994</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayle</surname><given-names>R</given-names></name><name><surname>Campbell</surname><given-names>IM</given-names></name><name><surname>Beck</surname><given-names>CR</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Wilson</surname><given-names>M</given-names></name><name><surname>Shaw</surname><given-names>CA</given-names></name><name><surname>Bjergbaek</surname><given-names>L</given-names></name><name><surname>Lupski</surname><given-names>JR</given-names></name><name><surname>Ira</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mus81 and converging forks limit the mutagenicity of replication fork breakage</article-title><source>Science</source><volume>349</volume><fpage>742</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.1126/science.aaa8391</pub-id><pub-id pub-id-type="pmid">26273056</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDaniel</surname><given-names>LD</given-names></name><name><surname>Chester</surname><given-names>N</given-names></name><name><surname>Watson</surname><given-names>M</given-names></name><name><surname>Borowsky</surname><given-names>AD</given-names></name><name><surname>Leder</surname><given-names>P</given-names></name><name><surname>Schultz</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Chromosome instability and tumor predisposition inversely correlate with BLM protein levels</article-title><source>DNA Repair</source><volume>2</volume><fpage>1387</fpage><lpage>1404</lpage><pub-id pub-id-type="doi">10.1016/j.dnarep.2003.08.006</pub-id><pub-id pub-id-type="pmid">14642567</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>A</given-names></name><name><surname>Haber</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Sources of DNA double-strand breaks and models of recombinational DNA repair</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>6</volume><elocation-id>a016428</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a016428</pub-id><pub-id pub-id-type="pmid">25104768</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mesin</surname><given-names>L</given-names></name><name><surname>Ersching</surname><given-names>J</given-names></name><name><surname>Victora</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Germinal center B cell dynamics</article-title><source>Immunity</source><volume>45</volume><fpage>471</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.09.001</pub-id><pub-id pub-id-type="pmid">27653600</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>KN</given-names></name><name><surname>Victorelli</surname><given-names>SG</given-names></name><name><surname>Salmonowicz</surname><given-names>H</given-names></name><name><surname>Dasgupta</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Passos</surname><given-names>JF</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cytoplasmic DNA: sources, sensing, and role in aging and disease</article-title><source>Cell</source><volume>184</volume><fpage>5506</fpage><lpage>5526</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.09.034</pub-id><pub-id pub-id-type="pmid">34715021</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minocherhomji</surname><given-names>S</given-names></name><name><surname>Ying</surname><given-names>S</given-names></name><name><surname>Bjerregaard</surname><given-names>VA</given-names></name><name><surname>Bursomanno</surname><given-names>S</given-names></name><name><surname>Aleliunaite</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Mankouri</surname><given-names>HW</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Hickson</surname><given-names>ID</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Replication stress activates DNA repair synthesis in mitosis</article-title><source>Nature</source><volume>528</volume><fpage>286</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1038/nature16139</pub-id><pub-id pub-id-type="pmid">26633632</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohebi</surname><given-names>S</given-names></name><name><surname>Mizuno</surname><given-names>K</given-names></name><name><surname>Watson</surname><given-names>A</given-names></name><name><surname>Carr</surname><given-names>AM</given-names></name><name><surname>Murray</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Checkpoints are blind to replication restart and recombination intermediates that result in gross chromosomal rearrangements</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>6357</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms7357</pub-id><pub-id pub-id-type="pmid">25721418</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muramatsu</surname><given-names>M</given-names></name><name><surname>Kinoshita</surname><given-names>K</given-names></name><name><surname>Fagarasan</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>S</given-names></name><name><surname>Shinkai</surname><given-names>Y</given-names></name><name><surname>Honjo</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme</article-title><source>Cell</source><volume>102</volume><fpage>553</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)00078-7</pub-id><pub-id pub-id-type="pmid">11007474</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naim</surname><given-names>V</given-names></name><name><surname>Wilhelm</surname><given-names>T</given-names></name><name><surname>Debatisse</surname><given-names>M</given-names></name><name><surname>Rosselli</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>ERCC1 and MUS81-EME1 promote sister chromatid separation by processing late replication intermediates at common fragile sites during mitosis</article-title><source>Nature Cell Biology</source><volume>15</volume><fpage>1008</fpage><lpage>1015</lpage><pub-id pub-id-type="doi">10.1038/ncb2793</pub-id><pub-id pub-id-type="pmid">23811686</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olivero</surname><given-names>CE</given-names></name><name><surname>Martínez-Terroba</surname><given-names>E</given-names></name><name><surname>Zimmer</surname><given-names>J</given-names></name><name><surname>Liao</surname><given-names>C</given-names></name><name><surname>Tesfaye</surname><given-names>E</given-names></name><name><surname>Hooshdaran</surname><given-names>N</given-names></name><name><surname>Schofield</surname><given-names>JA</given-names></name><name><surname>Bendor</surname><given-names>J</given-names></name><name><surname>Fang</surname><given-names>D</given-names></name><name><surname>Simon</surname><given-names>MD</given-names></name><name><surname>Zamudio</surname><given-names>JR</given-names></name><name><surname>Dimitrova</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>p53 activates the long noncoding RNA Pvt1b to inhibit Myc and suppress tumorigenesis</article-title><source>Molecular Cell</source><volume>77</volume><fpage>761</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2019.12.014</pub-id><pub-id pub-id-type="pmid">31973890</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ölmezer</surname><given-names>G</given-names></name><name><surname>Levikova</surname><given-names>M</given-names></name><name><surname>Klein</surname><given-names>D</given-names></name><name><surname>Falquet</surname><given-names>B</given-names></name><name><surname>Fontana</surname><given-names>GA</given-names></name><name><surname>Cejka</surname><given-names>P</given-names></name><name><surname>Rass</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Replication intermediates that escape Dna2 activity are processed by Holliday junction resolvase Yen1</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>13157</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms13157</pub-id><pub-id pub-id-type="pmid">27779184</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paludan</surname><given-names>SR</given-names></name><name><surname>Reinert</surname><given-names>LS</given-names></name><name><surname>Hornung</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer</article-title><source>Nature Reviews Immunology</source><volume>19</volume><fpage>141</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1038/s41577-018-0117-0</pub-id><pub-id pub-id-type="pmid">30644449</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pepe</surname><given-names>A</given-names></name><name><surname>West</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2014">2014a</year><article-title>MUS81-EME2 promotes replication fork restart</article-title><source>Cell Reports</source><volume>7</volume><fpage>1048</fpage><lpage>1055</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.04.007</pub-id><pub-id pub-id-type="pmid">24813886</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pepe</surname><given-names>A</given-names></name><name><surname>West</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2014">2014b</year><article-title>Substrate specificity of the MUS81-EME2 structure selective endonuclease</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>3833</fpage><lpage>3845</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt1333</pub-id><pub-id pub-id-type="pmid">24371268</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peschon</surname><given-names>JJ</given-names></name><name><surname>Morrissey</surname><given-names>PJ</given-names></name><name><surname>Grabstein</surname><given-names>KH</given-names></name><name><surname>Ramsdell</surname><given-names>FJ</given-names></name><name><surname>Maraskovsky</surname><given-names>E</given-names></name><name><surname>Gliniak</surname><given-names>BC</given-names></name><name><surname>Park</surname><given-names>LS</given-names></name><name><surname>Ziegler</surname><given-names>SF</given-names></name><name><surname>Williams</surname><given-names>DE</given-names></name><name><surname>Ware</surname><given-names>CB</given-names></name><name><surname>Meyer</surname><given-names>JD</given-names></name><name><surname>Davison</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice</article-title><source>The Journal of Experimental Medicine</source><volume>180</volume><fpage>1955</fpage><lpage>1960</lpage><pub-id pub-id-type="doi">10.1084/jem.180.5.1955</pub-id><pub-id pub-id-type="pmid">7964471</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petermann</surname><given-names>E</given-names></name><name><surname>Helleday</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Pathways of mammalian replication fork restart</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>11</volume><fpage>683</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1038/nrm2974</pub-id><pub-id pub-id-type="pmid">20842177</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pieper</surname><given-names>K</given-names></name><name><surname>Grimbacher</surname><given-names>B</given-names></name><name><surname>Eibel</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>B-cell biology and development</article-title><source>The Journal of Allergy and Clinical Immunology</source><volume>131</volume><fpage>959</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2013.01.046</pub-id><pub-id pub-id-type="pmid">23465663</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porter</surname><given-names>JR</given-names></name><name><surname>Fisher</surname><given-names>BE</given-names></name><name><surname>Baranello</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>JC</given-names></name><name><surname>Kambach</surname><given-names>DM</given-names></name><name><surname>Nie</surname><given-names>Z</given-names></name><name><surname>Koh</surname><given-names>WS</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Stommel</surname><given-names>JM</given-names></name><name><surname>Levens</surname><given-names>D</given-names></name><name><surname>Batchelor</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Global inhibition with specific activation: how p53 and MYC redistribute the transcriptome in the DNA double-strand break response</article-title><source>Molecular Cell</source><volume>67</volume><fpage>1013</fpage><lpage>1025</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.07.028</pub-id><pub-id pub-id-type="pmid">28867293</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ragu</surname><given-names>S</given-names></name><name><surname>Matos-Rodrigues</surname><given-names>G</given-names></name><name><surname>Lopez</surname><given-names>BS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Replication stress, DNA damage, inflammatory cytokines and innate immune response</article-title><source>Genes</source><volume>11</volume><elocation-id>409</elocation-id><pub-id pub-id-type="doi">10.3390/genes11040409</pub-id><pub-id pub-id-type="pmid">32283785</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rass</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Resolving branched DNA intermediates with structure-specific nucleases during replication in eukaryotes</article-title><source>Chromosoma</source><volume>122</volume><fpage>499</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1007/s00412-013-0431-z</pub-id><pub-id pub-id-type="pmid">24008669</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rush</surname><given-names>JS</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Odegard</surname><given-names>VH</given-names></name><name><surname>Unniraman</surname><given-names>S</given-names></name><name><surname>Schatz</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Expression of activation-induced cytidine deaminase is regulated by cell division, providing a mechanistic basis for division-linked class switch recombination</article-title><source>PNAS</source><volume>102</volume><fpage>13242</fpage><lpage>13247</lpage><pub-id pub-id-type="doi">10.1073/pnas.0502779102</pub-id><pub-id pub-id-type="pmid">16141332</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sachdeva</surname><given-names>M</given-names></name><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Walia</surname><given-names>V</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Elble</surname><given-names>R</given-names></name><name><surname>Watabe</surname><given-names>K</given-names></name><name><surname>Mo</surname><given-names>YY</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>p53 represses c-Myc through induction of the tumor suppressor miR-145</article-title><source>PNAS</source><volume>106</volume><fpage>3207</fpage><lpage>3212</lpage><pub-id pub-id-type="doi">10.1073/pnas.0808042106</pub-id><pub-id pub-id-type="pmid">19202062</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarbajna</surname><given-names>S</given-names></name><name><surname>Davies</surname><given-names>D</given-names></name><name><surname>West</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Roles of SLX1-SLX4, MUS81-EME1, and GEN1 in avoiding genome instability and mitotic catastrophe</article-title><source>Genes &amp; Development</source><volume>28</volume><fpage>1124</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.1101/gad.238303.114</pub-id><pub-id pub-id-type="pmid">24831703</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarlós</surname><given-names>K</given-names></name><name><surname>Biebricher</surname><given-names>A</given-names></name><name><surname>Petermann</surname><given-names>EJG</given-names></name><name><surname>Wuite</surname><given-names>GJL</given-names></name><name><surname>Hickson</surname><given-names>ID</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Knotty problems during mitosis: mechanistic insight into the processing of ultrafine DNA bridges in anaphase</article-title><source>Cold Spring Harbor Symposia on Quantitative Biology</source><volume>82</volume><fpage>187</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1101/sqb.2017.82.033647</pub-id><pub-id pub-id-type="pmid">29167280</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schatz</surname><given-names>DG</given-names></name><name><surname>Swanson</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>V(D)J recombination: mechanisms of initiation</article-title><source>Annual Review of Genetics</source><volume>45</volume><fpage>167</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1146/annurev-genet-110410-132552</pub-id><pub-id pub-id-type="pmid">21854230</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>EK</given-names></name><name><surname>Heyer</surname><given-names>WD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Processing of joint molecule intermediates by structure-selective endonucleases during homologous recombination in eukaryotes</article-title><source>Chromosoma</source><volume>120</volume><fpage>109</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1007/s00412-010-0304-7</pub-id><pub-id pub-id-type="pmid">21369956</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scully</surname><given-names>R</given-names></name><name><surname>Elango</surname><given-names>R</given-names></name><name><surname>Panday</surname><given-names>A</given-names></name><name><surname>Willis</surname><given-names>NA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Recombination and restart at blocked replication forks</article-title><source>Current Opinion in Genetics &amp; Development</source><volume>71</volume><fpage>154</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/j.gde.2021.08.003</pub-id><pub-id pub-id-type="pmid">34464818</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>N</given-names></name><name><surname>Akagawa</surname><given-names>R</given-names></name><name><surname>Takeda</surname><given-names>S</given-names></name><name><surname>Sasanuma</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The Mre11 nuclease promotes homologous recombination not only in DNA double-strand break resection but also in post-resection in human TK6 cells</article-title><source>Genome Instability &amp; Disease</source><volume>1</volume><fpage>184</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1007/s42764-020-00015-w</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skarnes</surname><given-names>WC</given-names></name><name><surname>Rosen</surname><given-names>B</given-names></name><name><surname>West</surname><given-names>AP</given-names></name><name><surname>Koutsourakis</surname><given-names>M</given-names></name><name><surname>Bushell</surname><given-names>W</given-names></name><name><surname>Iyer</surname><given-names>V</given-names></name><name><surname>Mujica</surname><given-names>AO</given-names></name><name><surname>Thomas</surname><given-names>M</given-names></name><name><surname>Harrow</surname><given-names>J</given-names></name><name><surname>Cox</surname><given-names>T</given-names></name><name><surname>Jackson</surname><given-names>D</given-names></name><name><surname>Severin</surname><given-names>J</given-names></name><name><surname>Biggs</surname><given-names>P</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Nefedov</surname><given-names>M</given-names></name><name><surname>de Jong</surname><given-names>PJ</given-names></name><name><surname>Stewart</surname><given-names>AF</given-names></name><name><surname>Bradley</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A conditional knockout resource for the genome-wide study of mouse gene function</article-title><source>Nature</source><volume>474</volume><fpage>337</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1038/nature10163</pub-id><pub-id pub-id-type="pmid">21677750</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Smolkin</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>RNA_Seq_MusGen</data-title><version designator="swh:1:rev:95ae9fe7b1ee8f820a0a8bafaba2e79fd758ab14">swh:1:rev:95ae9fe7b1ee8f820a0a8bafaba2e79fd758ab14</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:0742932f0e90d84db7f8c29ca31a1c3304a702f4;origin=https://github.com/ryashka/RNA_Seq_MusGen;visit=swh:1:snp:681c183001b42249886c316676785eadfab77c5a;anchor=swh:1:rev:95ae9fe7b1ee8f820a0a8bafaba2e79fd758ab14">https://archive.softwareheritage.org/swh:1:dir:0742932f0e90d84db7f8c29ca31a1c3304a702f4;origin=https://github.com/ryashka/RNA_Seq_MusGen;visit=swh:1:snp:681c183001b42249886c316676785eadfab77c5a;anchor=swh:1:rev:95ae9fe7b1ee8f820a0a8bafaba2e79fd758ab14</ext-link></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name><name><surname>Gillette</surname><given-names>MA</given-names></name><name><surname>Paulovich</surname><given-names>A</given-names></name><name><surname>Pomeroy</surname><given-names>SL</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>PNAS</source><volume>102</volume><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiwari</surname><given-names>A</given-names></name><name><surname>Addis Jones</surname><given-names>O</given-names></name><name><surname>Chan</surname><given-names>KL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>53BP1 can limit sister-chromatid rupture and rearrangements driven by a distinct ultrafine DNA bridging-breakage process</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>677</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-03098-y</pub-id><pub-id pub-id-type="pmid">29445165</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der Auwera</surname><given-names>GA</given-names></name><name><surname>Carneiro</surname><given-names>MO</given-names></name><name><surname>Hartl</surname><given-names>C</given-names></name><name><surname>Poplin</surname><given-names>R</given-names></name><name><surname>Del Angel</surname><given-names>G</given-names></name><name><surname>Levy-Moonshine</surname><given-names>A</given-names></name><name><surname>Jordan</surname><given-names>T</given-names></name><name><surname>Shakir</surname><given-names>K</given-names></name><name><surname>Roazen</surname><given-names>D</given-names></name><name><surname>Thibault</surname><given-names>J</given-names></name><name><surname>Banks</surname><given-names>E</given-names></name><name><surname>Garimella</surname><given-names>KV</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Gabriel</surname><given-names>S</given-names></name><name><surname>DePristo</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>From FastQ data to high confidence variant calls: the genome analysis toolkit best practices pipeline</article-title><source>Current Protocols in Bioinformatics</source><volume>43</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.1002/0471250953.bi1110s43</pub-id><pub-id pub-id-type="pmid">25431634</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Victora</surname><given-names>GD</given-names></name><name><surname>Nussenzweig</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Germinal centers</article-title><source>Annual Review of Immunology</source><volume>40</volume><fpage>413</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-120419-022408</pub-id><pub-id pub-id-type="pmid">35113731</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waisertreiger</surname><given-names>I</given-names></name><name><surname>Popovich</surname><given-names>K</given-names></name><name><surname>Block</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>KR</given-names></name><name><surname>Barlow</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Visualizing locus-specific sister chromatid exchange reveals differential patterns of replication stress-induced fragile site breakage</article-title><source>Oncogene</source><volume>39</volume><fpage>1260</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.1038/s41388-019-1054-5</pub-id><pub-id pub-id-type="pmid">31636383</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wechsler</surname><given-names>T</given-names></name><name><surname>Newman</surname><given-names>S</given-names></name><name><surname>West</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Aberrant chromosome morphology in human cells defective for Holliday junction resolution</article-title><source>Nature</source><volume>471</volume><fpage>642</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1038/nature09790</pub-id><pub-id pub-id-type="pmid">21399624</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West</surname><given-names>SC</given-names></name><name><surname>Blanco</surname><given-names>MG</given-names></name><name><surname>Chan</surname><given-names>YW</given-names></name><name><surname>Matos</surname><given-names>J</given-names></name><name><surname>Sarbajna</surname><given-names>S</given-names></name><name><surname>Wyatt</surname><given-names>HDM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Resolution of recombination intermediates: mechanisms and regulation</article-title><source>Cold Spring Harbor Symposia on Quantitative Biology</source><volume>80</volume><fpage>103</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1101/sqb.2015.80.027649</pub-id><pub-id pub-id-type="pmid">26370409</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West</surname><given-names>SC</given-names></name><name><surname>Chan</surname><given-names>YW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genome instability as a consequence of defects in the resolution of recombination intermediates</article-title><source>Cold Spring Harbor Symposia on Quantitative Biology</source><volume>82</volume><fpage>207</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1101/sqb.2017.82.034256</pub-id><pub-id pub-id-type="pmid">29348327</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><source>Ggplot2: Elegant Graphics for Data Analysis</source><publisher-loc>Cham</publisher-loc><publisher-name>Springer-Verlag</publisher-name><pub-id pub-id-type="doi">10.1007/978-3-319-24277-4</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wild</surname><given-names>P</given-names></name><name><surname>Matos</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cell cycle control of DNA joint molecule resolution</article-title><source>Current Opinion in Cell Biology</source><volume>40</volume><fpage>74</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2016.02.018</pub-id><pub-id pub-id-type="pmid">26970388</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Zan</surname><given-names>H</given-names></name><name><surname>Pone</surname><given-names>EJ</given-names></name><name><surname>Mai</surname><given-names>T</given-names></name><name><surname>Casali</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Immunoglobulin class-switch DNA recombination: induction, targeting and beyond</article-title><source>Nature Reviews Immunology</source><volume>12</volume><fpage>517</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1038/nri3216</pub-id><pub-id pub-id-type="pmid">22728528</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ying</surname><given-names>S</given-names></name><name><surname>Minocherhomji</surname><given-names>S</given-names></name><name><surname>Chan</surname><given-names>KL</given-names></name><name><surname>Palmai-Pallag</surname><given-names>T</given-names></name><name><surname>Chu</surname><given-names>WK</given-names></name><name><surname>Wass</surname><given-names>T</given-names></name><name><surname>Mankouri</surname><given-names>HW</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Hickson</surname><given-names>ID</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>MUS81 promotes common fragile site expression</article-title><source>Nature Cell Biology</source><volume>15</volume><fpage>1001</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1038/ncb2773</pub-id><pub-id pub-id-type="pmid">23811685</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>C</given-names></name><name><surname>Brink</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The unique biology of germinal center B cells</article-title><source>Immunity</source><volume>54</volume><fpage>1652</fpage><lpage>1664</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2021.07.015</pub-id><pub-id pub-id-type="pmid">34380063</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeman</surname><given-names>MK</given-names></name><name><surname>Cimprich</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Causes and consequences of replication stress</article-title><source>Nature Cell Biology</source><volume>16</volume><fpage>2</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/ncb2897</pub-id><pub-id pub-id-type="pmid">24366029</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Planells-Cases</surname><given-names>R</given-names></name><name><surname>Chu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>López-Cayuqueo</surname><given-names>KI</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Ullrich</surname><given-names>F</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Qian</surname><given-names>Z</given-names></name><name><surname>Liang</surname><given-names>X</given-names></name><name><surname>Cai</surname><given-names>SQ</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Leng</surname><given-names>Q</given-names></name><name><surname>Xiao</surname><given-names>TS</given-names></name><name><surname>Lan</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Peng</surname><given-names>C</given-names></name><name><surname>Qiu</surname><given-names>Z</given-names></name><name><surname>Jentsch</surname><given-names>TJ</given-names></name><name><surname>Xiao</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Transfer of cGAMP into bystander cells via LRRC8 volume-regulated anion channels augments STING-mediated interferon responses and anti-viral immunity</article-title><source>Immunity</source><volume>52</volume><fpage>767</fpage><lpage>781</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.03.016</pub-id><pub-id pub-id-type="pmid">32277911</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.77073.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Heyer</surname><given-names>Wolf-Dietrich</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05rrcem69</institution-id><institution>University of California, Davis</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.02.09.479711" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.02.09.479711"/></front-stub><body><p>This manuscript is of interest to individuals working on genome stability and B lymphocyte development. Using knockouts for the genes encoding the structure-selective endonucleases GEN1 and MUS81 in mice, the authors show that the absence of both proteins is incompatible with embryonic development. On the background of a GEN1 knockout, a MUS81 flox allele was used to study the effect on B-cell development using the Mb1-Cre and Cd23-Cre drivers, showing that the absence of both proteins leads to development and maturation defects. Selective loss in mature B cells inhibited germinal center formation. This is the first study of these enzymes in an organismic context and in primary cells, revealing insight into the in vivo consequences of loss of GEN1 and MUS81 functions not previously accessible through studies in cultured cells.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.77073.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Heyer</surname><given-names>Wolf-Dietrich</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05rrcem69</institution-id><institution>University of California, Davis</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Heyer</surname><given-names>Wolf-Dietrich</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05rrcem69</institution-id><institution>University of California, Davis</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.02.09.479711">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.02.09.479711v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;The Structure-Selective Endonucleases GEN1 and MUS81 are Functionally Complementary in Safeguarding the Genome of Proliferating B Lymphocytes&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Wolf-Dietrich Heyer as Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Jessica Tyler as the Senior Editor.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) The authors refer to GEN1 and MUS81 as Holliday junction resolvases. This terminology mischaracterizes the enzymes and inherently limits the type of DNA substrates that may be involved here. GEN1 can cleave HJs but also has a very broad substrate spectrum cleaving many types of branched and junction DNA molecules. MUS81 by itself is inactive, it requires EME1 to become a functional nuclease. MUS81-EME1 cannot cleave HJs, only in the context of the tri-nuclease <italic>SLX1</italic>-SLX4, MUS81-EME1, XPF-ERCC1. While I suspect the authors use this terminology as a shorthand and are aware of these complexities, many readers are not and will be misled. For this reason, the terminology, description, and discussion of these enzymes should be more precise. Both enzymes are structure-selective endonucleases. Just focusing on the HJ intermediate is also too narrow, as SDSA does not involve HJs and may be relevant here. MUS81-EME1 can cleave D-loops, another central HR intermediate, which may be of significance here. For these reasons, the concluding sentence of the introduction (line 135 ff) and many other passages should be rephrased to broaden the discussion of which specific molecular defects (dHJ resolution, other junction substrates, including stalled replication forks, etc.) underlie the observed phenotypes.</p><p>Note in Line 106, also MUS81-EME1 can cleave replication fork-type substrates.</p><p>2) The Mus81 flox allele should be described in more detail to indicate what exactly is predicted to be deleted in the encoded protein.</p><p>3) The results from the cell cycle analysis underline the indispensable role of GEN1 and MUS81 in supporting proliferation of activated B lymphocytes. These conclusions disregard another potentially interesting observation. The peak of the double knock-out splenocytes accumulated at 0 cell divisions (Figure 3B) is interpreted as cells that have not divided. How does deletion of proteins that participate in late homologous recombination repair affect the initiation of cell division? Could the authors provide a possible explanation?</p><p>4) Figure 5: The data presented on DNA damage are not convincing. It is the primary evidence that defective HR resolution is the cause, i.e. breaks at the same place on both sister arms. The images provided with damage classifications can be interpreted to either be different types of damage or undamaged chromosomes:</p><p>a) The picture labeled exchange can be caused by metaphase dropping – chromosome arms lay over each other does not mean that crossover occurred. It appears to be a radial or radial-like chromosome fusion.</p><p>b) The image labeled acentric is not an acentric chromosome, rather it is 2 chromosomes with 2 centromeres – the twin telomere foci in the middle look like the acrocentric arms at the centromere. Again, it is likely a fusion/damage event but appears to have a centromere by DNA + telomere staining.</p><p>c) The chromosome labeled dicentric has only one centromere at the top – again the twin telomere dots label the acrocentric arms at the centromere.</p><p>A commercially available centromere probe would aid with chromosome rearrangement analyses.</p><p>The interpretation in the manuscript relies heavily on published results to support the claim that the DKO mice are suffering from defective double Holliday junction (dHJ) resolution. However, if a dHJ persisted into mitosis without being resolved, why would this manifest as a chromosome break in a metaphase chromosome spread where the spindle has been destabilized with colcemid to &quot;trap&quot; cells in mitosis? Rather chromosome arms should be intertwined at the dHJ site which may not be visible at all, or visible as a &quot;pinch&quot; in the chromosome (picture 5F top left may actually be this, the &quot;pinch&quot; looking like a break -the DNA may be decondensed because of a HJ/dHJ?). This may be visible in the spreads: there are 4 chromosomes with this gap in them on both arms in Figure 5A. The HJ/dHJ and resulting UFB would only snap and create a &quot;true&quot; DSB on both sisters in anaphase when the spindle pulls the two sisters apart.</p><p>An increase in chromosome breaks is also a hallmark of defective NHEJ – double-strand breaks occurring in G1 are not repaired and then replicated leading to a chromosome break at same places on the sister. While this is unlikely for Gen1/Mus81-deficient cells, it is still formally possible.</p><p>5) Western Blot or genomic DNA analysis are necessary to assess the efficiency of Cre-mediated gene deletion in the different bone marrow cell populations. Deletion may be incomplete due to the late stage at which it acts and explain why germinal centers cells are only reduced ~2-fold in Figure 2A? The discussion regarding germinal center B cells independent of GEN1-MUS81 expression could be expanded.</p><p>6) The discussion of the results of the RNA-Seq analysis should be expanded. One of the most significantly downregulated pathways in the RNA-Seq are related to MYC targets. How does the deletion of the two resolvases connect to MYC?</p><p>7) The results of the RNA-Seq study are poorly discussed. While there is a clear experimental follow up on p53 pathway and apoptosis activation, What are the possible implications or causes of the interferon α response upregulation?</p><p><italic>Reviewer #1 (Comments for the Authors):</italic></p><p>Essential revision</p><p>1) The authors refer to GEN1 and MUS81 as Holliday junction resolvases. This terminology mischaracterizes the enzymes and inherently limits the type of DNA substrates that may be involved here. GEN1 can cleave HJs but also has a very broad substrate spectrum cleaving many types of branched and junction DNA molecules. MUS81 by itself is inactive, it requires EME1 to become a functional nuclease. MUS81-EME1 cannot cleave HJs, only in the context of the tri-nuclease <italic>SLX1</italic>-SLX4, MUS81-EME1, XPF-ERCC1. While I suspect the authors use this terminology as a shorthand and are aware of these complexities, many readers are not and will be misled. For this reason, the terminology, description, and discussion of these enzymes should be more precise. Both enzymes are structure-selective endonucleases. Just focusing on the HJ intermediate is also too narrow, as SDSA does not involve HJs and may be relevant here. MUS81-EME1 can cleave D-loops, another central HR intermediate, which may be of significance here. For these reasons, the concluding sentence of the introduction (line 135 ff) should be rephrased.</p><p>Note in Line 106, MUS81-EME1 can also cleave replication fork-type substrates.</p><p>2) The Mus81 flox allele should be described in more detail to indicate what exactly is predicted to be deleted in the encoded protein.</p><p><italic>Reviewer #2 (Comments for the Authors):</italic></p><p>1) The results from the cell cycle analysis underline the indispensable role of GEN1 and MUS81 in supporting proliferation of activated B lymphocytes. These conclusions disregard another potentially interesting observation. The peak of the double knock-out splenocytes accumulated at 0 cell divisions (Figure 3B) is interpreted as cells that have not divided. How does deletion of proteins that participate in late homologous recombination repair affect the initiation of cell division? Could the authors provide a possible explanation?</p><p>2) Since the authors assign the cell cycle block and increased apoptosis of the activated GEN1-MUS81 deficient B cells to p53-dependent pathways (Figure 4C), would a p53-deficient background rescue the phenotype observed in Figure 3? In reference to point 1 above, it would be of interest to see the consequences of p53 deficiency on the accumulation of the undivided population.</p><p>3) On the same line, one of the most significantly downregulated pathways in the RNA-Seq are related to MYC targets. How does the deletion of the two resolvases connect to MYC?</p><p>4) The results of the RNA-Seq study are poorly discussed. While there is a clear experimental follow up on p53 pathway and apoptosis activation, the authors do not discuss the possible implications or causes of the interferon α response upregulation.</p><p><italic>Reviewer #3 (Comments for the Authors):</italic></p><p>1) Adding class switch recombination frequencies for WT, Gen1, Mus81 and double-deficient cells would be appropriate to determine what programmed damage is occurring in this cell population. Though it is likely reduced due to low proliferation, it would still be interesting to see.</p><p>2) The data presented on DNA damage is not convincing. The images provided with damage classifications can be interpreted to either be different types of damage or undamaged chromosomes:</p><p>a) the picture labeled exchange can be caused by metaphase dropping – chromosome arms lay over each other does not mean that crossover occurred. It appears to be a radial or radial-like chromosome fusion.</p><p>b) The image labeled acentric is not an acentric chromosome, rather it is 2 chromosomes with 2 centromeres – the twin telomere foci in the middle look like the acrocentric arms at the centromere. Again it is likely a fusion/damage event but appears to have a centromere by DNA + telomere staining.</p><p>c) The chromosome labeled dicentric has only one centromere at the top – again the twin telomere dots label the acrocentric arms at the centromere.</p><p>A commercially available centromere probe would aid with chromosome rearrangement analyses.</p><p>3) Additional experiments to connect the developmental phenotypes to a defect in recombinational repair or replication stress would strengthen the conclusions of the manuscript in its current form. Do these cells exhibit reduced replication fork progression by DNA fiber analysis and/or activation of replication stress checkpoints (ATR / Chk1 phosphorylation)?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.77073.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The authors refer to GEN1 and MUS81 as Holliday junction resolvases. This terminology mischaracterizes the enzymes and inherently limits the type of DNA substrates that may be involved here. GEN1 can cleave HJs but also has a very broad substrate spectrum cleaving many types of branched and junction DNA molecules. MUS81 by itself is inactive, it requires EME1 to become a functional nuclease. MUS81-EME1 cannot cleave HJs, only in the context of the tri-nuclease SLX1-SLX4, MUS81-EME1, XPF-ERCC1. While I suspect the authors use this terminology as a shorthand and are aware of these complexities, many readers are not and will be misled. For this reason, the terminology, description, and discussion of these enzymes should be more precise. Both enzymes are structure-selective endonucleases. Just focusing on the HJ intermediate is also too narrow, as SDSA does not involve HJs and may be relevant here. MUS81-EME1 can cleave D-loops, another central HR intermediate, which may be of significance here. For these reasons, the concluding sentence of the introduction (line 135 ff) and many other passages should be rephrased to broaden the discussion of which specific molecular defects (dHJ resolution, other junction substrates, including stalled replication forks, etc.) underlie the observed phenotypes.</p><p>Note in Line 106, also MUS81-EME1 can cleave replication fork-type substrates.</p></disp-quote><p>We would like to thank the reviewers for bringing this up and in response, we have changed the terminology and description of these enzymes, referring them as ‘structure-selective endonucleases’ consistently throughout the manuscript to reflect their broad substrate specificity and to minimize reader confusion. We also have modified and expanded the Introduction and Discussion sections to recognize and elaborate on the possibility that the molecular defects underpinning the developmental and immunological phenotypes observed in the B-cell-specific <italic>Gen1</italic>-<italic>Mus81</italic>-null mice might involve the persistence of other non-HJ joint and branched structures that necessitate GEN1 and MUS81 processing, consequently impairing a greater variety of DNA replication and recombination events beyond what we have described initially.</p><disp-quote content-type="editor-comment"><p>2) The Mus81 flox allele should be described in more detail to indicate what exactly is predicted to be deleted in the encoded protein.</p></disp-quote><p>We have revised the text to describe the location of the loxP sites and the region of the protein that is being deleted in the floxed <italic>Mus81</italic> mouse.</p><disp-quote content-type="editor-comment"><p>3) The results from the cell cycle analysis underline the indispensable role of GEN1 and MUS81 in supporting proliferation of activated B lymphocytes. These conclusions disregard another potentially interesting observation. The peak of the double knock-out splenocytes accumulated at 0 cell divisions (Figure 3B) is interpreted as cells that have not divided. How does deletion of proteins that participate in late homologous recombination repair affect the initiation of cell division? Could the authors provide a possible explanation?</p></disp-quote><p>This is a very astute comment by the reviewer. In response, we quantified the absolute number of division- zero cells under all conditions of stimulation and found it to similar across all genotype groups, indicating that a small subset of B cells does not undergo cell division under any condition. As fewer viable, proliferating DKO cells were present in the 72-hour culture, the undivided (division-zero) cells are thus disproportionately represented in the DKO B cell culture compared with those in the control and SKO B cell cultures, producing the “enriched” division-zero peak in Figure 3C. We have included this data in Figure 3D and Figure 3—figure supplement 1C.</p><p>And, as the reviewer has noted, while GEN1 and MUS81 have canonically been associated with the resolution of structural intermediates generated during HR (primarily HJs), they could also act on a more diverse array of DNA substrates, including those formed independently of recombinational DSB repair (i.e., during replication). Therefore, the inability of DKO cells to initiate cell division or sustain multiple rounds of replication could reflect a failure to eliminate replication-induced junction molecules, the persistence of which leads to G2/M stalling and abrogation of a complete cell division. These possibilities have now been described in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>4) Figure 5: The data presented on DNA damage are not convincing. It is the primary evidence that defective HR resolution is the cause, i.e. breaks at the same place on both sister arms. The images provided with damage classifications can be interpreted to either be different types of damage or undamaged chromosomes:</p><p>a) The picture labeled exchange can be caused by metaphase dropping – chromosome arms lay over each other does not mean that crossover occurred. It appears to be a radial or radial-like chromosome fusion.</p></disp-quote><p>We thank the reviewer for this comment. We agree with the reviewer, and we have corrected the labeling to read as “radial”. We are confident that we have counted radial structures in our analysis, and we have included additional examples of what has been identified as a radial in Figure 5—figure supplement 1.</p><disp-quote content-type="editor-comment"><p>b) The image labeled acentric is not an acentric chromosome, rather it is 2 chromosomes with 2 centromeres – the twin telomere foci in the middle look like the acrocentric arms at the centromere. Again, it is likely a fusion/damage event but appears to have a centromere by DNA + telomere staining.</p></disp-quote><p>We have called these structures “acentrics” because they appear to be so by Giemsa staining; only by Tel-FISH could one observe a radial structure involving the short arms of two chromosomes. We agree that this should have been addressed in the original text, and we have added discussion to this effect and additional examples of 'acentrics' in Figure 5—figure supplement 1.</p><disp-quote content-type="editor-comment"><p>c) The chromosome labeled dicentric has only one centromere at the top – again the twin telomere dots label the acrocentric arms at the centromere.</p><p>A commercially available centromere probe would aid with chromosome rearrangement analyses.</p></disp-quote><p>This chromosome appears to have two centromeres due to the additional constriction, but it is impossible to be certain of this without doing centromere staining (although mouse chromosomes are acrocentric, lack of additional telomere signal does not preclude an additional centromere being present). This is one instance where we respectfully disagree with the reviewer. We believe that performing the centromere staining would not add significant value to the paper given that dicentrics do not represent a major class of aberration in the DKO cells and removing the dicentrics from our analysis would not impact the conclusions of the paper.</p><disp-quote content-type="editor-comment"><p>The interpretation in the manuscript relies heavily on published results to support the claim that the DKO mice are suffering from defective double Holliday junction (dHJ) resolution. However, if a dHJ persisted into mitosis without being resolved, why would this manifest as a chromosome break in a metaphase chromosome spread where the spindle has been destabilized with colcemid to &quot;trap&quot; cells in mitosis? Rather chromosome arms should be intertwined at the dHJ site which may not be visible at all, or visible as a &quot;pinch&quot; in the chromosome (picture 5F top left may actually be this, the &quot;pinch&quot; looking like a break -the DNA may be decondensed because of a HJ/dHJ?). This may be visible in the spreads: there are 4 chromosomes with this gap in them on both arms in Figure 5A. The HJ/dHJ and resulting UFB would only snap and create a &quot;true&quot; DSB on both sisters in anaphase when the spindle pulls the two sisters apart.</p></disp-quote><p>We agree that the breaks could be persistent HJs disrupting chromosome condensation, as has been previously suggested in the literature. However, prior to the chromosome analysis, some of these cells would have been through multiple cell cycles, so these could also be true breaks that are the result of an unresolved HJ that was broken in the previous mitosis. Although not directly tested by us in our DKO cells, the West lab recently showed that these unresolved recombination intermediates form ultrafine anaphase bridges that are broken during cytokinesis, generating DNA ends amenable to NHEJ-mediated chromosomal fusions (Chan et al., 2018, <italic>Nature Cell Biology</italic>). We have discussed these possibilities in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>An increase in chromosome breaks is also a hallmark of defective NHEJ – double-strand breaks occurring in G1 are not repaired and then replicated leading to a chromosome break at same places on the sister. While this is unlikely for Gen1/Mus81-deficient cells, it is still formally possible.</p></disp-quote><p>We agree with the reviewer, and we have now acknowledged this possibility in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>5) Western Blot or genomic DNA analysis are necessary to assess the efficiency of Cre-mediated gene deletion in the different bone marrow cell populations. Deletion may be incomplete due to the late stage at which it acts and explain why germinal centers cells are only reduced ~2-fold in Figure 2A? The discussion regarding germinal center B cells independent of GEN1-MUS81 expression could be expanded.</p></disp-quote><p>We performed quantitative genomic PCR to determine the efficiency of <italic>Mus81</italic> deletion, and RT-qPCR to measure <italic>Gen1</italic> and <italic>Mus81</italic> mRNA expressions in Fractions B+C (pro-B and pre-B) cells of <italic>Gen1</italic><sup>+/–</sup> <italic>Mus81</italic><sup>fl/fl</sup>, <italic>Gen1</italic><sup>–/–</sup> <italic>Mus81</italic><sup>fl/fl</sup>, and <italic>Mb1</italic>-Cre: <italic>Gen1</italic><sup>+/–</sup> <italic>Mus81</italic><sup>fl/fl</sup>. <italic>Mb1</italic>-Cre: <italic>Gen1</italic><sup>+/–</sup> <italic>Mus81</italic><sup>fl/fl</sup> mice do not possess Fractions B+C cells and so these analyses could not be performed. We have included the data in Figure 1—figure supplement 1E and 1F. We want to note that despite several attempts with various commercial and lab-made antibodies using protein amounts as high as 100 μg, we were unable to reliably detect mouse GEN1 and MUS81 proteins in our ex vivo B cell cultures.</p><p>We did not analyze the deletion efficiency in Fraction A (pre-pro-B) cells because we recently realized from unrelated experiments that the “Fraction A” cells defined by the gating strategy employed in our manuscript is composed predominantly (~90%) of plasmacytoid dendritic cells that are positive for B220 and negative for the same set of B-lineage markers used in our experiment. We were only able to identify these contaminating plasmacytoid dendritic cells by including anti-Siglec-H and anti-Cd11c antibodies in our staining panel. (We now realize this is a common omission made by others in the field.) We have therefore decided to remove all data related to the Fraction A population from Figure 1 and have revised the Results section. The conclusion that the loss of <italic>Gen1</italic> and <italic>Mus81</italic> in early B-cell progenitors impairs the development of mature B cells, however, is unaffected despite the exclusion of the data as Fraction B cells are almost completely absent in the <italic>Mb1-Cre</italic>: <italic>Gen1</italic><sup>+/–</sup> <italic>Mus81</italic><sup>fl/fl</sup> mice.</p><disp-quote content-type="editor-comment"><p>6) The discussion of the results of the RNA-Seq analysis should be expanded. One of the most significantly downregulated pathways in the RNA-Seq are related to MYC targets. How does the deletion of the two resolvases connect to MYC?</p></disp-quote><p>In agreement with this comment, we have expanded the discussion of the RNA-seq findings. Porter et al., (2017, <italic>Molecular Cell</italic>) reported that p53 upregulation in response to DNA damage suppresses MYC transcription via the binding of p53 to an enhancer region within a MYC super-enhancer element, and that such transcriptional inhibition is necessary for the proper enforcement of p53-dependent cell cycle arrest in cells experiencing a high level of genotoxic stress. This MYC-counteracting mechanism would thus be similarly engaged in DKO cells that exhibit gross genomic destabilization and high p53 activity. Furthermore, the transcriptional targets of p53 can directly suppress MYC expression via other transcriptional (by the lncRNA <italic>Pvt1b</italic>) and post-transcriptional (by miR-145 and miR-34b) mechanisms, and indirectly via the inhibition of mTOR (by TSC2 and PTEN), the upstream regulator of MYC (Cui et al., 2021, <italic>Frontiers in Cell and Developmental Biology</italic>; Levine, 2020, <italic>Nature Reviews Cancer</italic>; Olivero et al., 2020, <italic>Molecular Cell</italic>; Sachdeva et al., 2009, <italic>PNAS</italic>).</p><p>In addition, we have generated and extensively characterized the <italic>Cd23</italic>-Cre: <italic>Gen1</italic><sup>-/-</sup> <italic>Mus81</italic><sup>fl/fl</sup> <italic>Trp53</italic><sup>fl/fl</sup> mice to examine whether the inactivation of p53 can ameliorate the DKO phenotype. Loss of p53 did not improve any of the defects observed in the DKO cells, suggesting that the DNA damage sustained by the proliferating DKO cells might be too extensive for their survival. These findings are now presented in the Results section and included in Figure 4—figure supplement 2.</p><disp-quote content-type="editor-comment"><p>7) The results of the RNA-Seq study are poorly discussed. While there is a clear experimental follow up on p53 pathway and apoptosis activation, What are the possible implications or causes of the interferon α response upregulation?</p></disp-quote><p>We apologize for the brevity of the RNA-seq discussion. In the revised text, we have now expanded on how the sensing of cytosolic DNAs (e.g., micronuclei, free DNAs) by cGAS and the subsequent activation of an immune signaling cascade induces the type I IFN transcriptional program. We have also elaborated on the role type I IFN signaling might play in DNA-stimulated cell death, particularly in activating effector proteins involved in apoptosis and necroptosis (Paludan et al., 2019, <italic>Nature Reviews Immunology</italic>). Further, activation of the adaptor protein STING by cGAS has recently been implicated in the upregulation of p53 signaling in T cells, and this could potentially occur in our ex vivo-activated endonuclease-deficient B cells to elicit apoptosis (Concepcion et al., 2022, <italic>Nature Immunology</italic>).</p></body></sub-article></article>